2025-09-19 |
13D/A
|
|
|
|
1,988,657 |
|
|
|
2025-09-19 |
13G
|
|
|
|
1,675,000 |
|
|
|
2025-09-08 |
13D/A
|
MLYS / Mineralys Therapeutics, Inc.
|
|
6,287,597 |
7,796,433 |
|
|
|
2025-08-29 |
13G
|
IVVD / Invivyd, Inc.
|
|
|
21,338,288 |
|
|
|
2025-08-26 |
13G/A
|
ADGM / Adagio Medical Holdings, Inc.
|
|
0 |
1,200,000 |
|
|
|
2025-08-20 |
13G/A
|
CRVO / CervoMed Inc.
|
|
0 |
1,026,937 |
|
|
|
2025-08-18 |
13G
|
ASMB / Assembly Biosciences, Inc.
|
|
628,092 |
1,530,615 |
|
|
|
2025-08-14 |
13G/A
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
6,011,112 |
593,670 |
|
|
|
2025-08-14 |
13G/A
|
URGN / UroGen Pharma Ltd.
|
|
3,206,271 |
0 |
|
|
|
2025-08-14 |
13G/A
|
TSHA / Taysha Gene Therapies, Inc.
|
|
21,539,465 |
25,345,988 |
|
|
|
2025-08-14 |
13G/A
|
STRO / Sutro Biopharma, Inc.
|
|
4,434,637 |
0 |
|
|
|
2025-08-14 |
13G/A
|
SERA / Sera Prognostics, Inc.
|
|
3,032,808 |
0 |
|
|
|
2025-08-14 |
13D/A
|
SLDB / Solid Biosciences Inc.
|
|
|
7,997,510 |
|
|
|
2025-08-14 |
13G/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
6,084,412 |
5,561,359 |
|
|
|
2025-08-14 |
13G/A
|
TARA / Protara Therapeutics, Inc.
|
|
3,431,713 |
1,971,765 |
|
|
|
2025-08-14 |
13G/A
|
GHRS / GH Research PLC
|
|
6,944,648 |
7,676,697 |
|
|
|
2025-08-14 |
13G/A
|
DAWN / Day One Biopharmaceuticals, Inc.
|
|
5,755,577 |
0 |
|
|
|
2025-08-14 |
13G/A
|
CRVO / CervoMed Inc.
|
|
916,063 |
0 |
|
|
|
2025-08-14 |
13G/A
|
BOLD / Boundless Bio, Inc.
|
|
2,180,631 |
0 |
|
|
|
2025-08-14 |
13G/A
|
ATXS / Astria Therapeutics, Inc.
|
|
5,105,213 |
0 |
|
|
|
2025-08-14 |
13G/A
|
ALEC / Alector, Inc.
|
|
9,695,228 |
0 |
|
|
|
2025-08-14 |
13G/A
|
ADGM / Adagio Medical Holdings, Inc.
|
|
1,200,000 |
0 |
|
|
|
2025-08-11 |
13D/A
|
CDTX / Cidara Therapeutics, Inc.
|
|
3,365,523 |
3,365,523 |
|
|
|
2025-07-25 |
13G
|
CTNM / Contineum Therapeutics, Inc.
|
|
|
2,122,000 |
|
|
|
2025-06-30 |
13D/A
|
CDTX / Cidara Therapeutics, Inc.
|
|
1,092,796 |
3,365,523 |
|
|
|
2025-06-27 |
13D/A
|
VOR / Vor Biopharma Inc.
|
|
39,709,850 |
39,739,850 |
|
|
|
2025-06-06 |
13D/A
|
TYRA / Tyra Biosciences, Inc.
|
|
10,684,890 |
11,899,788 |
|
|
|
2025-05-19 |
13D/A
|
ITOS / iTeos Therapeutics, Inc.
|
|
4,163,276 |
2,134,806 |
|
|
|
2025-05-15 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
4,368,998 |
4,004,610 |
|
|
|
2025-05-15 |
13G/A
|
NAMS / NewAmsterdam Pharma Company N.V.
|
|
10,875,454 |
11,063,125 |
|
|
|
2025-05-15 |
13G/A
|
GHRS / GH Research PLC
|
|
6,686,689 |
6,944,648 |
|
|
|
2025-05-15 |
13G/A
|
UNCY / Unicycive Therapeutics, Inc.
|
|
11,520,120 |
13,285,781 |
|
|
|
2025-05-15 |
13G/A
|
GERN / Geron Corporation
|
|
63,319,553 |
63,988,106 |
|
|
|
2025-05-15 |
13G/A
|
DYN / Dyne Therapeutics, Inc.
|
|
6,381,144 |
9,714,392 |
|
|
|
2025-05-15 |
13G/A
|
DNTH / Dianthus Therapeutics, Inc.
|
|
2,866,733 |
2,866,733 |
|
|
|
2025-05-15 |
13G/A
|
SRZN / Surrozen, Inc.
|
|
323,662 |
867,418 |
|
|
|
2025-05-15 |
13G/A
|
CMRX / Chimerix, Inc.
|
|
8,800,000 |
0 |
|
|
|
2025-05-15 |
13G/A
|
CCCC / C4 Therapeutics, Inc.
|
|
4,878,000 |
0 |
|
|
|
2025-05-15 |
13G/A
|
URGN / UroGen Pharma Ltd.
|
|
3,206,271 |
3,206,271 |
|
|
|
2025-05-15 |
13G/A
|
DRUG / Bright Minds Biosciences Inc.
|
|
460,829 |
206,427 |
|
|
|
2025-05-15 |
13G/A
|
PCVX / Vaxcyte, Inc.
|
|
12,649,728 |
12,964,491 |
|
|
|
2025-05-15 |
13G/A
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
7,777,942 |
6,011,112 |
|
|
|
2025-05-15 |
13G/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
967,299 |
1,094,407 |
|
|
|
2025-05-15 |
13G/A
|
ADGM / Adagio Medical Holdings, Inc.
|
|
1,613,220 |
1,200,000 |
|
|
|
2025-05-14 |
13D/A
|
ITOS / iTeos Therapeutics, Inc.
|
|
3,659,046 |
4,163,276 |
|
|
|
2025-05-14 |
13D/A
|
HOWL / Werewolf Therapeutics, Inc.
|
|
6,192,881 |
6,746,807 |
|
|
|
2025-05-09 |
13D/A
|
LENZ / LENZ Therapeutics, Inc.
|
|
4,250,856 |
4,260,606 |
|
|
|
2025-04-30 |
13D/A
|
JBIO / Jade Biosciences, Inc.
|
|
|
1,324,954 |
|
|
|
2025-04-04 |
13G
|
STRO / Sutro Biopharma, Inc.
|
|
|
4,434,637 |
|
|
|
2025-03-31 |
13D/A
|
ABOS / Acumen Pharmaceuticals, Inc.
|
|
14,981,618 |
15,016,063 |
|
|
|
2025-03-31 |
13D/A
|
TYRA / Tyra Biosciences, Inc.
|
|
10,677,140 |
10,684,890 |
|
|
|
2025-03-17 |
13D/A
|
MLYS / Mineralys Therapeutics, Inc.
|
|
4,949,307 |
6,287,597 |
|
|
|
2025-03-10 |
13D/A
|
JANX / Janux Therapeutics, Inc.
|
|
10,443,181 |
11,971,377 |
|
|
|
2025-03-03 |
13D/A
|
ETNB / 89bio, Inc.
|
|
20,013,733 |
20,013,733 |
|
|
|
2025-02-21 |
13D/A
|
SLDB / Solid Biosciences Inc.
|
|
4,358,478 |
|
|
|
|
2025-02-18 |
13D
|
SION / Sionna Therapeutics, Inc.
|
|
|
|
|
|
|
2025-02-14 |
13G/A
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
8,460,090 |
7,777,942 |
|
|
|
2025-02-14 |
13G/A
|
TNYA / Tenaya Therapeutics, Inc.
|
|
7,980,736 |
0 |
|
|
|
2025-02-14 |
13G/A
|
UNCY / Unicycive Therapeutics, Inc.
|
|
10,472,375 |
11,520,120 |
|
|
|
2025-02-14 |
13G/A
|
RXRX / Recursion Pharmaceuticals, Inc.
|
|
15,384,615 |
7,725,096 |
|
|
|
2025-02-14 |
13G/A
|
NAMS / NewAmsterdam Pharma Company N.V.
|
|
9,095,589 |
10,875,454 |
|
|
|
2025-02-14 |
13G/A
|
TARA / Protara Therapeutics, Inc.
|
|
2,073,075 |
3,431,713 |
|
|
|
2025-02-14 |
13G/A
|
MGNX / MacroGenics, Inc.
|
|
4,053,077 |
0 |
|
|
|
2025-02-14 |
13G/A
|
LBPH / Longboard Pharmaceuticals, Inc.
|
|
3,073,119 |
0 |
|
|
|
2025-02-14 |
13G/A
|
GLYC / GlycoMimetics, Inc.
|
|
6,383,000 |
0 |
|
|
|
2025-02-14 |
13G/A
|
EYPT / EyePoint Pharmaceuticals, Inc.
|
|
3,095,136 |
3,181,818 |
|
|
|
2025-02-14 |
13G/A
|
EVH / Evolent Health, Inc.
|
|
8,279,103 |
3,577,197 |
|
|
|
2025-02-14 |
13G/A
|
|
|
|
0 |
|
|
|
2025-02-14 |
13G/A
|
DNTH / Dianthus Therapeutics, Inc.
|
|
2,995,023 |
2,866,733 |
|
|
|
2025-02-14 |
13G/A
|
ADGM / Adagio Medical Holdings, Inc.
|
|
1,337,813 |
1,613,220 |
|
|
|
2025-02-14 |
13G/A
|
DAWN / Day One Biopharmaceuticals, Inc.
|
|
7,809,852 |
5,755,577 |
|
|
|
2025-02-14 |
13G/A
|
FDMT / 4D Molecular Therapeutics, Inc.
|
|
5,098,211 |
4,564,867 |
|
|
|
2025-02-14 |
13G/A
|
|
|
58,139,535 |
0 |
|
|
|
2025-02-14 |
13G/A
|
CTKB / Cytek Biosciences, Inc.
|
|
6,809,404 |
0 |
|
|
|
2025-02-14 |
13G/A
|
CRVO / CervoMed Inc.
|
|
825,373 |
916,063 |
|
|
|
2025-02-14 |
13G/A
|
BIOA / BioAge Labs, Inc.
|
|
2,210,589 |
1,310,589 |
|
|
|
2025-02-14 |
13G/A
|
ANTX / AN2 Therapeutics, Inc.
|
|
1,999,997 |
0 |
|
|
|
2025-02-14 |
13G/A
|
ANRO / Alto Neuroscience, Inc.
|
|
2,075,154 |
0 |
|
|
|
2025-02-14 |
13G/A
|
MNPR / Monopar Therapeutics Inc.
|
|
511,207 |
620,116 |
|
|
|
2025-02-14 |
13G/A
|
ZURA / Zura Bio Limited
|
|
3,217,503 |
3,217,503 |
|
|
|
2025-02-03 |
13D/A
|
ETNB / 89bio, Inc.
|
|
14,254,298 |
20,013,733 |
|
|
|
2024-12-30 |
13D/A
|
VOR / Vor Biopharma Inc.
|
|
22,780,343 |
39,709,850 |
|
|
|
2024-12-06 |
13G
|
ALEC / Alector, Inc.
|
|
|
9,695,228 |
|
|
|
2024-12-05 |
13G
|
KURA / Kura Oncology, Inc.
|
|
|
4,368,998 |
|
|
|
2024-11-26 |
13D/A
|
CDTX / Cidara Therapeutics, Inc.
|
|
703,080 |
1,092,796 |
|
|
|
2024-11-22 |
13G
|
ACLX / Arcellx, Inc.
|
|
|
2,787,327 |
|
|
|
2024-11-18 |
13D/A
|
ETNB / 89bio, Inc.
|
|
14,254,298 |
14,254,298 |
|
|
|
2024-11-15 |
13G/A
|
FDMT / 4D Molecular Therapeutics, Inc.
|
|
5,202,145 |
5,098,211 |
|
|
|
2024-11-14 |
13G/A
|
PCVX / Vaxcyte, Inc.
|
|
9,685,079 |
12,649,728 |
|
|
|
2024-11-14 |
13G/A
|
ELVN / Enliven Therapeutics, Inc.
|
|
|
1,061,233 |
|
|
|
2024-11-14 |
13G/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
5,330,412 |
6,084,412 |
|
|
|
2024-11-14 |
13G/A
|
APGE / Apogee Therapeutics, Inc.
|
|
1,977,901 |
1,961,863 |
|
|
|
2024-11-14 |
13G/A
|
RNA / Avidity Biosciences, Inc.
|
|
4,895,959 |
6,300,408 |
|
|
|
2024-11-14 |
13G/A
|
ACET / Adicet Bio, Inc.
|
|
7,696,949 |
8,308,532 |
|
|
|
2024-11-14 |
13G/A
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
7,503,976 |
8,460,090 |
|
|
|
2024-11-14 |
13G/A
|
ANRO / Alto Neuroscience, Inc.
|
|
1,385,491 |
2,075,154 |
|
|
|
2024-11-14 |
13G/A
|
GHRS / GH Research PLC
|
|
5,587,333 |
6,686,689 |
|
|
|
2024-11-14 |
13G/A
|
GERN / Geron Corporation
|
|
55,145,502 |
63,319,553 |
|
|
|
2024-11-14 |
13G/A
|
RXST / RxSight, Inc.
|
|
3,404,285 |
3,916,825 |
|
|
|
2024-11-14 |
13G/A
|
ATXS / Astria Therapeutics, Inc.
|
|
4,413,150 |
5,105,213 |
|
|
|
2024-11-14 |
13G/A
|
CELC / Celcuity Inc.
|
|
1,286,960 |
1,286,960 |
|
|
|
2024-11-14 |
13G/A
|
SERA / Sera Prognostics, Inc.
|
|
2,047,221 |
3,032,808 |
|
|
|
2024-11-14 |
13G/A
|
FDMT / 4D Molecular Therapeutics, Inc.
|
|
4,163,211 |
5,202,145 |
|
|
|
2024-11-14 |
13G/A
|
URGN / UroGen Pharma Ltd.
|
|
3,083,558 |
3,206,271 |
|
|
|
2024-11-14 |
13G/A
|
RGLS / Regulus Therapeutics Inc.
|
|
6,250,000 |
766,834 |
|
|
|
2024-11-14 |
13G/A
|
PRAX / Praxis Precision Medicines, Inc.
|
|
1,235,599 |
761,955 |
|
|
|
2024-11-14 |
13G/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
10,107,400 |
9,710,428 |
|
|
|
2024-11-14 |
13G/A
|
TSHA / Taysha Gene Therapies, Inc.
|
|
18,670,089 |
21,539,465 |
|
|
|
2024-11-14 |
13G/A
|
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
2,253,000 |
2,253,000 |
|
|
|
2024-11-14 |
13G/A
|
UNCY / Unicycive Therapeutics, Inc.
|
|
3,472,106 |
10,472,375 |
|
|
|
2024-11-14 |
13G/A
|
TRML / Tourmaline Bio, Inc.
|
|
2,045,028 |
2,538,925 |
|
|
|
2024-11-14 |
13G/A
|
DYN / Dyne Therapeutics, Inc.
|
|
5,213,661 |
6,381,144 |
|
|
|
2024-11-14 |
13G/A
|
TNYA / Tenaya Therapeutics, Inc.
|
|
6,948,236 |
7,980,736 |
|
|
|
2024-11-14 |
13G/A
|
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
|
|
7,225,311 |
5,690,316 |
|
|
|
2024-11-14 |
13G/A
|
THRD / Third Harmonic Bio, Inc.
|
|
2,033,056 |
1,280,826 |
|
|
|
2024-11-14 |
13G/A
|
NAMS / NewAmsterdam Pharma Company N.V.
|
|
8,197,333 |
9,095,589 |
|
|
|
2024-11-13 |
13D/A
|
TYRA / Tyra Biosciences, Inc.
|
|
10,091,071 |
10,677,140 |
|
|
|
2024-11-12 |
13G
|
DRUG / Bright Minds Biosciences Inc.
|
|
|
460,829 |
|
|
|
2024-11-06 |
13G
|
GLYC / GlycoMimetics, Inc.
|
|
|
6,383,000 |
|
|
|
2024-11-06 |
13G
|
ENSC / Ensysce Biosciences, Inc.
|
|
|
1,476,000 |
|
|
|
2024-11-05 |
13G
|
ELDN / Eledon Pharmaceuticals, Inc.
|
|
|
3,566,338 |
|
|
|
2024-11-04 |
13D
|
SEPN / Septerna, Inc.
|
|
|
6,995,858 |
|
|
|
2024-10-31 |
13G
|
MNPR / Monopar Therapeutics Inc.
|
|
|
511,207 |
|
|
|
2024-10-22 |
13D/A
|
TYRA / Tyra Biosciences, Inc.
|
|
10,475,489 |
10,091,071 |
|
|
|
2024-10-22 |
13D/A
|
JANX / Janux Therapeutics, Inc.
|
|
10,742,993 |
10,443,181 |
|
|
|
2024-10-07 |
13G
|
BIOA / BioAge Labs, Inc.
|
|
|
2,210,589 |
|
|
|
2024-10-01 |
13D/A
|
WVE / Wave Life Sciences Ltd.
|
|
17,269,811 |
25,414,165 |
|
|
|
2024-09-23 |
13D
|
BCAX / Bicara Therapeutics Inc.
|
|
|
6,955,993 |
|
|
|
2024-09-16 |
13D/A
|
JANX / Janux Therapeutics, Inc.
|
|
10,593,395 |
10,742,993 |
|
|
|
2024-09-16 |
13G/A
|
FULC / Fulcrum Therapeutics, Inc.
|
|
5,544,216 |
10,229,099 |
|
|
|
2024-09-03 |
13D/A
|
ARTV / Artiva Biotherapeutics, Inc.
|
|
9,853,302 |
9,853,302 |
|
|
|
2024-08-23 |
13G
|
AVTX / Avalo Therapeutics, Inc.
|
|
|
967,299 |
|
|
|
2024-08-23 |
13G/A
|
FULC / Fulcrum Therapeutics, Inc.
|
|
11,609,704 |
5,544,216 |
|
|
|
2024-08-13 |
13G/A
|
ANTX / AN2 Therapeutics, Inc.
|
|
5,551,295 |
1,999,997 |
|
|
|
2024-08-12 |
13G
|
ADGM / Adagio Medical Holdings, Inc.
|
|
|
1,337,813 |
|
|
|
2024-08-07 |
13D/A
|
ETNB / 89bio, Inc.
|
|
14,254,298 |
14,254,298 |
|
|
|
2024-07-29 |
13D
|
ARTV / Artiva Biotherapeutics, Inc.
|
|
|
9,853,302 |
|
|
|
2024-07-25 |
13D
|
CDTX / Cidara Therapeutics, Inc.
|
|
0 |
703,080 |
|
|
|
2024-07-08 |
13G
|
RXRX / Recursion Pharmaceuticals, Inc.
|
|
|
15,384,615 |
|
|
|
2024-07-01 |
13G
|
PRAX / Praxis Precision Medicines, Inc.
|
|
|
1,235,599 |
|
|
|
2024-07-01 |
13D/A
|
CLYM / Climb Bio, Inc.
|
|
13,190,849 |
31,459,267 |
|
|
|
2024-06-24 |
13G
|
PCSC / Perceptive Capital Solutions Corp
|
|
|
750,000 |
|
|
|
2024-06-20 |
13D/A
|
AVTE / Aerovate Therapeutics, Inc.
|
|
8,313,982 |
9,242,092 |
|
|
|
2024-06-17 |
13G
|
EVH / Evolent Health, Inc.
|
|
|
8,279,103 |
|
|
|
2024-06-12 |
13D/A
|
SLDB / Solid Biosciences Inc.
|
|
4,348,828 |
4,358,478 |
|
|
|
2024-06-07 |
13G
|
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
2,253,000 |
|
|
|
2024-06-06 |
13D/A
|
CLYM / Climb Bio, Inc.
|
|
13,190,292 |
13,190,849 |
|
|
|
2024-06-03 |
13G
|
TRML / Tourmaline Bio, Inc.
|
|
0 |
2,045,028 |
|
|
|
2024-05-30 |
13G
|
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
|
|
|
7,225,311 |
|
|
|
2024-05-17 |
13D/A
|
CLYM / Climb Bio, Inc.
|
|
13,189,736 |
13,190,292 |
|
|
|
2024-05-14 |
13D/A
|
ITOS / iTeos Therapeutics, Inc.
|
|
4,417,259 |
3,659,046 |
|
|
|
2024-05-10 |
13G
|
MDNAF / Medicenna Therapeutics Corp.
|
|
|
7,714,760 |
|
|
|
2024-05-09 |
13D/A
|
BDTX / Black Diamond Therapeutics, Inc.
|
|
2,589,904 |
2,788,028 |
|
|
|
2024-05-07 |
13D/A
|
HOWL / Werewolf Therapeutics, Inc.
|
|
6,179,035 |
6,192,881 |
|
|
|
2024-05-06 |
13G
|
RNA / Avidity Biosciences, Inc.
|
|
2,454,533 |
4,895,959 |
|
|
|
2024-05-02 |
13G
|
ZURA / Zura Bio Limited
|
|
|
3,217,503 |
|
|
|
2024-04-30 |
13D/A
|
AVTE / Aerovate Therapeutics, Inc.
|
|
8,293,148 |
8,313,982 |
|
|
|
2024-04-25 |
13G
|
TARA / Protara Therapeutics, Inc.
|
|
1,679,205 |
2,073,075 |
|
|
|
2024-04-15 |
13G
|
SRZN / Surrozen, Inc.
|
|
|
323,662 |
|
|
|
2024-04-12 |
13D/A
|
CLYM / Climb Bio, Inc.
|
|
13,179,181 |
13,189,736 |
|
|
|
2024-04-12 |
13G
|
BOLD / Boundless Bio, Inc.
|
|
|
2,180,631 |
|
|
|
2024-04-11 |
13G
|
CRVO / CervoMed Inc.
|
|
|
825,373 |
|
|
|
2024-04-11 |
13D/A
|
ACRV / Acrivon Therapeutics, Inc.
|
|
4,817,359 |
8,359,102 |
|
|
|
2024-04-04 |
13G
|
DYN / Dyne Therapeutics, Inc.
|
|
0 |
5,213,661 |
|
|
|
2024-04-01 |
13G
|
SERA / Sera Prognostics, Inc.
|
|
|
2,047,221 |
|
|
|
2024-03-29 |
13D/A
|
NKTX / Nkarta, Inc.
|
|
7,832,340 |
13,848,371 |
|
|
|
2024-03-29 |
13D/A
|
SPRY / ARS Pharmaceuticals, Inc.
|
|
9,459,678 |
10,860,977 |
|
|
|
2024-03-29 |
13G
|
ANRO / Alto Neuroscience, Inc.
|
|
|
1,385,491 |
|
|
|
2024-03-28 |
13D
|
LENZ / LENZ Therapeutics, Inc.
|
|
|
4,250,856 |
|
|
|
2024-03-25 |
13G
|
RGLS / Regulus Therapeutics Inc.
|
|
0 |
6,250,000 |
|
|
|
2024-03-25 |
13G
|
CYBN / Cybin Inc.
|
|
|
58,139,535 |
|
|
|
2024-03-18 |
13D/A
|
CLYM / Climb Bio, Inc.
|
|
13,176,403 |
13,179,181 |
|
|
|
2024-03-11 |
13D/A
|
PEPG / PepGen Inc.
|
|
10,695,135 |
10,695,135 |
|
|
|
2024-03-06 |
13D/A
|
JANX / Janux Therapeutics, Inc.
|
|
8,670,644 |
10,593,395 |
|
|
|
2024-03-06 |
13D/A
|
ETNB / 89bio, Inc.
|
|
12,875,855 |
14,254,298 |
|
|
|
2024-02-27 |
13D/A
|
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
|
|
3,062,871 |
0 |
|
|
|
2024-02-26 |
13G
|
LRMR / Larimar Therapeutics, Inc.
|
|
0 |
6,045,351 |
|
|
|
2024-02-22 |
13G
|
CTKB / Cytek Biosciences, Inc.
|
|
6,809,404 |
6,809,404 |
|
|
|
2024-02-21 |
13D/A
|
ICVX / Icosavax, Inc.
|
|
5,985,843 |
0 |
|
|
|
2024-02-14 |
13G/A
|
EYPT / EyePoint Pharmaceuticals, Inc.
|
|
3,408,706 |
3,095,136 |
|
|
|
2024-02-14 |
13G/A
|
UNCY / Unicycive Therapeutics, Inc.
|
|
3,470,689 |
3,472,106 |
|
|
|
2024-02-14 |
13G/A
|
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
0 |
|
|
|
2024-02-14 |
13D/A
|
HOWL / Werewolf Therapeutics, Inc.
|
|
6,159,054 |
6,179,035 |
|
|
|
2024-02-14 |
13G/A
|
TRML / Tourmaline Bio, Inc.
|
|
|
0 |
|
|
|
2024-02-14 |
13G/A
|
NKTR / Nektar Therapeutics
|
|
18,700,000 |
0 |
|
|
|
2024-02-14 |
13G/A
|
CMRX / Chimerix, Inc.
|
|
6,501,624 |
8,800,000 |
|
|
|
2024-02-14 |
13G/A
|
FDMT / 4D Molecular Therapeutics, Inc.
|
|
2,789,721 |
4,163,211 |
|
|
|
2024-02-14 |
13G/A
|
IMGN / ImmunoGen, Inc.
|
|
22,075,158 |
26,916,027 |
|
|
|
2024-02-14 |
13G/A
|
HLVX / HilleVax, Inc.
|
|
1,760,019 |
0 |
|
|
|
2024-02-14 |
13G/A
|
ACRS / Aclaris Therapeutics, Inc.
|
|
4,398,453 |
0 |
|
|
|
2024-02-14 |
13G/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
5,516,067 |
5,330,412 |
|
|
|
2024-02-14 |
13G/A
|
NSTGQ / NS Wind Down Co., Inc.
|
|
2,577,373 |
0 |
|
|
|
2024-02-14 |
13G/A
|
COGT / Cogent Biosciences, Inc.
|
|
5,999,481 |
0 |
|
|
|
2024-02-14 |
13G/A
|
URGN / UroGen Pharma Ltd.
|
|
3,083,550 |
3,083,558 |
|
|
|
2024-02-14 |
13G/A
|
NAMS / NewAmsterdam Pharma Company N.V.
|
|
9,333,333 |
8,197,333 |
|
|
|
2024-02-14 |
13G/A
|
MGNX / MacroGenics, Inc.
|
|
3,764,871 |
4,053,077 |
|
|
|
2024-02-14 |
13G/A
|
HARP / Harpoon Therapeutics, Inc.
|
|
1,701,570 |
1,712,792 |
|
|
|
2024-02-14 |
13G/A
|
RXST / RxSight, Inc.
|
|
3,052,796 |
3,404,285 |
|
|
|
2024-02-14 |
13G/A
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
7,691,990 |
7,503,976 |
|
|
|
2024-02-14 |
13G/A
|
TNYA / Tenaya Therapeutics, Inc.
|
|
6,428,483 |
6,948,236 |
|
|
|
2024-02-14 |
13G/A
|
CELC / Celcuity Inc.
|
|
2,249,421 |
1,286,960 |
|
|
|
2024-02-14 |
13G/A
|
TSHA / Taysha Gene Therapies, Inc.
|
|
18,690,868 |
18,670,089 |
|
|
|
2024-02-14 |
13G
|
APGE / Apogee Therapeutics, Inc.
|
|
|
1,977,901 |
|
|
|
2024-02-14 |
13G/A
|
PCVX / Vaxcyte, Inc.
|
|
8,153,559 |
9,685,079 |
|
|
|
2024-02-14 |
13G/A
|
INBX.V / Inhibrx, Inc.
|
|
3,853,867 |
4,724,352 |
|
|
|
2024-02-14 |
13G/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
4,397,368 |
5,903,234 |
|
|
|
2024-02-14 |
13G/A
|
GERN / Geron Corporation
|
|
48,423,211 |
55,145,502 |
|
|
|
2024-02-14 |
13G/A
|
RNA / Avidity Biosciences, Inc.
|
|
5,454,533 |
2,454,533 |
|
|
|
2024-02-14 |
13G/A
|
FULC / Fulcrum Therapeutics, Inc.
|
|
9,686,628 |
11,609,704 |
|
|
|
2024-02-14 |
13G/A
|
DAWN / Day One Biopharmaceuticals, Inc.
|
|
7,040,622 |
7,809,852 |
|
|
|
2024-02-14 |
13G/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
9,967,172 |
10,107,400 |
|
|
|
2024-02-14 |
13G/A
|
GHRS / GH Research PLC
|
|
5,561,118 |
5,587,333 |
|
|
|
2024-02-14 |
13G/A
|
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
|
|
48,600,300 |
48,600,221 |
|
|
|
2024-02-14 |
13G/A
|
CVAC / CureVac N.V.
|
|
|
2,744,270 |
|
|
|
2024-02-14 |
13G/A
|
ANTX / AN2 Therapeutics, Inc.
|
|
3,773,517 |
5,551,295 |
|
|
|
2024-02-13 |
13D/A
|
PEPG / PepGen Inc.
|
|
8,131,952 |
10,695,135 |
|
|
|
2024-02-12 |
13D/A
|
MLYS / Mineralys Therapeutics, Inc.
|
|
3,180,920 |
4,949,307 |
|
|
|
2024-02-12 |
13G
|
CRBP / Corbus Pharmaceuticals Holdings, Inc.
|
|
|
430,182 |
|
|
|
2024-02-12 |
13G
|
ATXS / Astria Therapeutics, Inc.
|
|
0 |
4,413,150 |
|
|
|
2024-02-06 |
13D/A
|
TYRA / Tyra Biosciences, Inc.
|
|
7,236,454 |
10,475,489 |
|
|
|
2024-02-05 |
13G
|
ACET / Adicet Bio, Inc.
|
|
0 |
7,696,949 |
|
|
|
2024-02-02 |
13G
|
DNTH / Dianthus Therapeutics, Inc.
|
|
2,995,023 |
2,995,023 |
|
|
|
2024-01-29 |
13G
|
EWTX / Edgewise Therapeutics, Inc.
|
|
0 |
8,909,091 |
|
|
|
2024-01-19 |
13G
|
VXRT / Vaxart, Inc.
|
|
|
15,384,615 |
|
|
|
2024-01-12 |
13G
|
LBPH / Longboard Pharmaceuticals, Inc.
|
|
|
3,073,119 |
|
|
|
2024-01-11 |
13D/A
|
SLDB / Solid Biosciences Inc.
|
|
3,431,618 |
4,348,828 |
|
|
|
2023-12-29 |
13G
|
URGN / UroGen Pharma Ltd.
|
|
|
3,083,550 |
|
|
|
2023-12-26 |
13G
|
CCCC / C4 Therapeutics, Inc.
|
|
|
4,878,000 |
|
|
|
2023-12-20 |
13D/A
|
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
|
|
5,124,309 |
3,062,871 |
|
|
|
2023-12-14 |
13D/A
|
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
|
|
5,955,011 |
5,124,309 |
|
|
|
2023-12-13 |
13D/A
|
ETNB / 89bio, Inc.
|
|
12,874,814 |
12,875,855 |
|
|
|
2023-12-04 |
13D/A
|
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
|
|
6,991,003 |
5,955,011 |
|
|
|
2023-11-27 |
13G
|
THRD / Third Harmonic Bio, Inc.
|
|
534,687 |
2,033,056 |
|
|
|
2023-11-17 |
13D/A
|
CLYM / Climb Bio, Inc.
|
|
13,163,071 |
13,176,403 |
|
|
|
2023-11-14 |
13G/A
|
DSGN / Design Therapeutics, Inc.
|
|
2,971,231 |
0 |
|
|
|
2023-11-06 |
13G
|
HARP / Harpoon Therapeutics, Inc.
|
|
|
1,701,570 |
|
|
|
2023-10-30 |
13G
|
MGNX / MacroGenics, Inc.
|
|
0 |
3,764,871 |
|
|
|
2023-10-05 |
13G
|
SLNO / Soleno Therapeutics, Inc.
|
|
|
1,233,300 |
|
|
|
2023-09-29 |
13G
|
CMRX / Chimerix, Inc.
|
|
|
6,501,624 |
|
|
|
2023-09-25 |
13D/A
|
SPRY / ARS Pharmaceuticals, Inc.
|
|
6,759,678 |
9,459,678 |
|
|
|
2023-09-22 |
13G
|
CBAY / CymaBay Therapeutics, Inc.
|
|
|
6,940,000 |
|
|
|
2023-09-19 |
13D/A
|
CTKB / Cytek Biosciences, Inc.
|
|
13,139,327 |
6,809,404 |
|
|
|
2023-08-31 |
13D
|
SPRY / ARS Pharmaceuticals, Inc.
|
|
1,742,186 |
6,759,678 |
|
|
|
2023-08-25 |
13G
|
TSHA / Taysha Gene Therapies, Inc.
|
|
|
18,690,868 |
|
|
|
2023-08-21 |
13G
|
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
|
|
|
48,600,300 |
|
|
|
2023-08-17 |
13G
|
NKTR / Nektar Therapeutics
|
|
|
18,700,000 |
|
|
|
2023-08-14 |
13G/A
|
BLU / BluEnergies Ltd.
|
|
12,452,574 |
0 |
|
|
|
2023-08-14 |
13G/A
|
KNTE / Kinnate Biopharma Inc.
|
|
4,264,144 |
0 |
|
|
|
2023-08-11 |
13D/A
|
VOR / Vor Biopharma Inc.
|
|
22,760,145 |
22,780,343 |
|
|
|
2023-08-11 |
13D/A
|
ETNB / 89bio, Inc.
|
|
12,876,898 |
12,874,814 |
|
|
|
2023-08-09 |
13D/A
|
DICE / DICE Therapeutics Inc
|
|
7,877,862 |
0 |
|
|
|
2023-08-01 |
13G/A
|
NAMS / NewAmsterdam Pharma Company N.V.
|
|
|
9,333,333 |
|
|
|
2023-07-25 |
13D/A
|
ABOS / Acumen Pharmaceuticals, Inc.
|
|
9,774,551 |
14,981,618 |
|
|
|
2023-07-06 |
13G
|
TALS / Talaris Therapeutics Inc
|
|
|
2,333,175 |
|
|
|
2023-07-06 |
13G
|
UNCY / Unicycive Therapeutics, Inc.
|
|
|
3,470,689 |
|
|
|
2023-06-27 |
13D/A
|
AVTE / Aerovate Therapeutics, Inc.
|
|
8,263,982 |
8,293,148 |
|
|
|
2023-06-21 |
13D/A
|
DICE / DICE Therapeutics Inc
|
|
7,660,615 |
7,877,862 |
|
|
|
2023-06-12 |
13D/A
|
STSA / Satsuma Pharmaceuticals Inc
|
|
5,944,252 |
0 |
|
|
|
2023-06-05 |
13G
|
FDMT / 4D Molecular Therapeutics, Inc.
|
|
|
2,789,721 |
|
|
|
2023-05-30 |
13D/A
|
ICVX / Icosavax, Inc.
|
|
5,779,347 |
5,985,843 |
|
|
|
2023-05-15 |
13G/A
|
DALS / DA32 Life Science Tech Acquisition Corp - Class A
|
|
1,500,000 |
0 |
|
|
|
2023-05-15 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
3,984,681 |
0 |
|
|
|
2023-05-15 |
13G/A
|
ARYE / ARYA Sciences Acquisition Corp V - Class A
|
|
1,000,000 |
0 |
|
|
|
2023-04-18 |
13D/A
|
STSA / Satsuma Pharmaceuticals Inc
|
|
|
5,944,252 |
|
|
|
2023-04-10 |
13G
|
NSTGQ / NS Wind Down Co., Inc.
|
|
143,900 |
2,577,373 |
|
|
|
2023-04-10 |
13D/A
|
CLYM / Climb Bio, Inc.
|
|
13,151,959 |
13,163,071 |
|
|
|
2023-04-10 |
13G/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
6,957,179 |
9,967,172 |
|
|
|
2023-03-30 |
13G/A
|
GHRS / GH Research PLC
|
|
4,898,373 |
5,561,118 |
|
|
|
2023-03-30 |
13D/A
|
ACRV / Acrivon Therapeutics, Inc.
|
|
4,813,442 |
4,817,359 |
|
|
|
2023-03-30 |
13D/A
|
ETNB / 89bio, Inc.
|
|
9,376,402 |
12,876,898 |
|
|
|
2023-03-29 |
13D/A
|
DICE / DICE Therapeutics Inc
|
|
6,848,911 |
7,660,615 |
|
|
|
2023-03-27 |
13G
|
CVAC / CureVac N.V.
|
|
|
12,245,955 |
|
|
|
2023-03-20 |
13G
|
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
|
|
0 |
18,564,300 |
|
|
|
2023-02-27 |
13G/A
|
IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF
|
|
3,250,724 |
2,122,465 |
|
|
|
2023-02-24 |
13D
|
MLYS / Mineralys Therapeutics, Inc.
|
|
|
3,180,920 |
|
|
|
2023-02-14 |
13G/A
|
EYPT / EyePoint Pharmaceuticals, Inc.
|
|
1,606,859 |
3,408,706 |
|
|
|
2023-02-14 |
13G/A
|
INBX.V / Inhibrx, Inc.
|
|
3,185,831 |
3,853,867 |
|
|
|
2023-02-14 |
13G/A
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
48,778,172 |
7,691,990 |
|
|
|
2023-02-14 |
13G/A
|
IOBT / IO Biotech, Inc.
|
|
1,857,755 |
1,127,260 |
|
|
|
2023-02-14 |
13G/A
|
BLU / Bellus Health Inc
|
|
10,230,274 |
12,452,574 |
|
|
|
2023-02-14 |
13G/A
|
PYXS / Pyxis Oncology, Inc.
|
|
2,282,173 |
0 |
|
|
|
2023-02-14 |
13G/A
|
COGT / Cogent Biosciences, Inc.
|
|
3,588,081 |
5,999,481 |
|
|
|
2023-02-14 |
13G/A
|
MIST / Milestone Pharmaceuticals Inc.
|
|
2,246,503 |
0 |
|
|
|
2023-02-14 |
13G/A
|
PCVX / Vaxcyte, Inc.
|
|
3,865,808 |
8,153,559 |
|
|
|
2023-02-14 |
13G/A
|
ENTX / Entera Bio Ltd.
|
|
2,353,000 |
295,966 |
|
|
|
2023-02-14 |
13G/A
|
DAWN / Day One Biopharmaceuticals, Inc.
|
|
4,965,588 |
7,040,622 |
|
|
|
2023-02-14 |
13G/A
|
ACET / Adicet Bio, Inc.
|
|
2,364,351 |
0 |
|
|
|
2023-02-14 |
13G/A
|
IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF
|
|
3,220,825 |
3,250,724 |
|
|
|
2023-02-14 |
13G/A
|
CELC / Celcuity Inc.
|
|
1,486,471 |
2,249,421 |
|
|
|
2023-02-14 |
13G/A
|
GHRS / GH Research PLC
|
|
2,843,757 |
4,898,373 |
|
|
|
2023-02-14 |
13G/A
|
KNTE / Kinnate Biopharma Inc.
|
|
3,593,052 |
4,264,144 |
|
|
|
2023-02-14 |
13G/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
7,567,900 |
6,957,179 |
|
|
|
2023-02-14 |
13G/A
|
THRD / Third Harmonic Bio, Inc.
|
|
|
534,687 |
|
|
|
2023-02-14 |
13G/A
|
PHASQ / PhaseBio Pharmaceuticals, Inc.
|
|
2,850,000 |
0 |
|
|
|
2023-02-14 |
13G/A
|
NSTGQ / NS Wind Down Co., Inc.
|
|
3,517,694 |
143,900 |
|
|
|
2023-02-14 |
13G/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
4,356,632 |
4,397,368 |
|
|
|
2023-02-14 |
13G
|
OBIO / Orchestra BioMed Holdings, Inc.
|
|
|
610,283 |
|
|
|
2023-02-14 |
13G/A
|
VERA / Vera Therapeutics, Inc.
|
|
2,000,000 |
0 |
|
|
|
2023-02-14 |
13G/A
|
BLSA / BCLS Acquisition Corp - Class A
|
|
1,250,000 |
0 |
|
|
|
2023-02-14 |
13G
|
HLVX / HilleVax, Inc.
|
|
|
1,760,019 |
|
|
|
2023-02-14 |
13G/A
|
ANTX / AN2 Therapeutics, Inc.
|
|
3,666,663 |
3,773,517 |
|
|
|
2023-02-14 |
13G/A
|
GERN / Geron Corporation
|
|
32,388,799 |
48,423,211 |
|
|
|
2023-02-14 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
5,614,428 |
3,984,681 |
|
|
|
2023-02-14 |
13G/A
|
RLMD / Relmada Therapeutics, Inc.
|
|
2,000,000 |
0 |
|
|
|
2023-02-14 |
13G/A
|
SYBX / Synlogic, Inc.
|
|
6,666,666 |
0 |
|
|
|
2023-02-14 |
13G/A
|
MGTA / Magenta Therapeutics Inc
|
|
3,588,081 |
0 |
|
|
|
2023-02-14 |
13G/A
|
PRDS / Pardes Biosciences Inc
|
|
4,431,901 |
0 |
|
|
|
2023-02-14 |
13G/A
|
TIL / Instil Bio, Inc.
|
|
7,670,793 |
0 |
|
|
|
2023-02-14 |
13G/A
|
FVAM / 5:01 Acquisition Corp.
|
|
750,000 |
0 |
|
|
|
2023-02-14 |
13G/A
|
TNYA / Tenaya Therapeutics, Inc.
|
|
3,551,508 |
6,428,483 |
|
|
|
2023-02-14 |
13G/A
|
IMGN / ImmunoGen, Inc.
|
|
22,162,958 |
22,075,158 |
|
|
|
2023-02-14 |
13G/A
|
CNCE / Concert Pharmaceuticals Inc
|
|
3,510,103 |
5,199,746 |
|
|
|
2023-02-14 |
13G/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
4,871,067 |
5,516,067 |
|
|
|
2023-01-10 |
13D/A
|
HOWL / Werewolf Therapeutics, Inc.
|
|
4,304,447 |
6,159,054 |
|
|
|
2023-01-06 |
13G/A
|
FULC / Fulcrum Therapeutics, Inc.
|
|
7,000,000 |
9,686,628 |
|
|
|
2022-12-30 |
13D/A
|
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
|
|
2,976,943 |
1,607,834 |
|
|
|
2022-12-30 |
13G
|
RNA / Avidity Biosciences, Inc.
|
|
|
5,454,533 |
|
|
|
2022-12-23 |
13D/A
|
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
|
|
4,107,508 |
2,976,943 |
|
|
|
2022-12-15 |
13D/A
|
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
|
|
5,014,687 |
4,107,508 |
|
|
|
2022-12-09 |
13D/A
|
VOR / Vor Biopharma Inc.
|
|
11,131,300 |
22,760,145 |
|
|
|
2022-12-05 |
13D/A
|
SLDB / Solid Biosciences Inc.
|
|
12,447,873 |
3,431,618 |
|
|
|
2022-12-02 |
13G
|
NAMS / NewAmsterdam Pharma Company N.V.
|
|
|
4,333,333 |
|
|
|
2022-11-28 |
13D
|
ACRV / Acrivon Therapeutics, Inc.
|
|
|
4,813,442 |
|
|
|
2022-11-14 |
13D/A
|
VOR / Vor Biopharma Inc.
|
|
11,120,973 |
11,131,300 |
|
|
|
2022-11-14 |
13G/A
|
/ LIANBIO
|
|
7,655,015 |
0 |
|
|
|
2022-11-14 |
13G/A
|
ATXS / Astria Therapeutics, Inc.
|
|
1,262,193 |
0 |
|
|
|
2022-11-14 |
13G/A
|
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
|
|
9,694,789 |
0 |
|
|
|
2022-11-14 |
13G/A
|
VERU / Veru Inc.
|
|
7,900,000 |
0 |
|
|
|
2022-11-14 |
13G/A
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
0 |
0 |
|
|
|
2022-11-14 |
13G/A
|
DYN / Dyne Therapeutics, Inc.
|
|
2,805,045 |
0 |
|
|
|
2022-11-14 |
13G/A
|
XLO / Xilio Therapeutics, Inc.
|
|
2,002,217 |
0 |
|
|
|
2022-11-14 |
13G/A
|
OTIC / Otonomy Inc
|
|
5,600,000 |
0 |
|
|
|
2022-11-14 |
13G/A
|
LAB / Standard BioTools Inc.
|
|
4,651,177 |
0 |
|
|
|
2022-11-14 |
13G/A
|
LRMR / Larimar Therapeutics, Inc.
|
|
1,334,610 |
0 |
|
|
|
2022-10-24 |
13G
|
IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF
|
|
|
3,220,825 |
|
|
|
2022-10-21 |
13D/A
|
ETNB / 89bio, Inc.
|
|
7,806,169 |
9,376,402 |
|
|
|
2022-10-19 |
13D/A
|
DICE / DICE Therapeutics Inc
|
|
5,208,911 |
6,848,911 |
|
|
|
2022-10-17 |
13G
|
INBX.V / Inhibrx, Inc.
|
|
0 |
3,185,831 |
|
|
|
2022-10-17 |
13G
|
ACET / Adicet Bio, Inc.
|
|
|
2,364,351 |
|
|
|
2022-10-14 |
13D/A
|
FMTX / Forma Therapeutics Holdings Inc
|
|
9,040,309 |
0 |
|
|
|
2022-10-13 |
13G
|
DSGN / Design Therapeutics, Inc.
|
|
|
2,971,231 |
|
|
|
2022-10-04 |
13D/A
|
SLDB / Solid Biosciences Inc.
|
|
12,447,873 |
12,447,873 |
|
|
|
2022-10-03 |
13G
|
ALPN / Alpine Immune Sciences, Inc.
|
|
|
4,356,632 |
|
|
|
2022-09-27 |
13G/A
|
MGTA / Magenta Therapeutics Inc
|
|
|
3,588,081 |
|
|
|
2022-09-26 |
13D/A
|
PNT / POINT Biopharma Global Inc.
|
|
9,003,018 |
0 |
|
|
|
2022-09-26 |
13G
|
COGT / Cogent Biosciences, Inc.
|
|
3,612,207 |
3,588,081 |
|
|
|
2022-09-26 |
13G
|
THRD / Third Harmonic Bio, Inc.
|
|
|
3,475,687 |
|
|
|
2022-09-16 |
13D/A
|
PNT / POINT Biopharma Global Inc.
|
|
9,003,018 |
9,003,018 |
|
|
|
2022-09-06 |
13D/A
|
SLDB / Solid Biosciences Inc.
|
|
12,367,873 |
12,447,873 |
|
|
|
2022-09-06 |
13G
|
COGT / Cogent Biosciences, Inc.
|
|
|
3,612,207 |
|
|
|
2022-09-02 |
13D/A
|
FMTX / Forma Therapeutics Holdings Inc
|
|
9,029,184 |
9,040,309 |
|
|
|
2022-08-29 |
13D/A
|
PNT / POINT Biopharma Global Inc.
|
|
8,856,018 |
9,003,018 |
|
|
|
2022-08-26 |
13G
|
FULC / Fulcrum Therapeutics, Inc.
|
|
|
7,000,000 |
|
|
|
2022-08-15 |
13G/A
|
SCPH / scPharmaceuticals Inc.
|
|
2,691,770 |
0 |
|
|
|
2022-08-15 |
13G/A
|
MGNX / MacroGenics, Inc.
|
|
6,103,594 |
0 |
|
|
|
2022-08-15 |
13G/A
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
1,930,322 |
0 |
|
|
|
2022-08-15 |
13G/A
|
TCRX / TScan Therapeutics, Inc.
|
|
1,255,317 |
0 |
|
|
|
2022-08-15 |
13G/A
|
EWTX / Edgewise Therapeutics, Inc.
|
|
2,613,623 |
0 |
|
|
|
2022-08-15 |
13G/A
|
AKUS / Akouos Inc
|
|
2,281,249 |
0 |
|
|
|
2022-08-15 |
13G/A
|
CYTT / Cyteir Therapeutics, Inc.
|
|
3,350,506 |
0 |
|
|
|
2022-08-12 |
13D/A
|
HOWL / Werewolf Therapeutics, Inc.
|
|
3,968,583 |
4,304,447 |
|
|
|
2022-07-06 |
13D/A
|
ETNB / 89bio, Inc.
|
|
4,291,881 |
7,806,169 |
|
|
|
2022-06-23 |
13D/A
|
PEPG / PepGen Inc.
|
|
8,131,952 |
8,131,952 |
|
|
|
2022-06-22 |
13G
|
TIL / Instil Bio, Inc.
|
|
|
7,670,793 |
|
|
|
2022-06-21 |
13D/A
|
WVE / Wave Life Sciences Ltd.
|
|
7,828,457 |
17,269,811 |
|
|
|
2022-06-03 |
13D/A
|
KALA / KALA BIO, Inc.
|
|
6,194,789 |
3,412,868 |
|
|
|
2022-06-01 |
13D/A
|
KALA / KALA BIO, Inc.
|
|
8,045,299 |
6,194,789 |
|
|
|
2022-05-25 |
13D/A
|
KALA / KALA BIO, Inc.
|
|
10,914,613 |
8,045,299 |
|
|
|
2022-05-25 |
13G
|
CELC / Celcuity Inc.
|
|
|
1,486,471 |
|
|
|
2022-05-20 |
13D
|
PEPG / PepGen Inc.
|
|
|
8,131,952 |
|
|
|
2022-05-16 |
13G/A
|
BOLT / Bolt Biotherapeutics, Inc.
|
|
2,378,325 |
0 |
|
|
|
2022-05-16 |
13G/A
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
2,150,404 |
0 |
|
|
|
2022-05-16 |
13G/A
|
PHAT / Phathom Pharmaceuticals, Inc.
|
|
3,115,008 |
0 |
|
|
|
2022-05-16 |
13G/A
|
ZGNX / Zogenix Inc
|
|
3,333,700 |
0 |
|
|
|
2022-05-02 |
13D/A
|
NKTX / Nkarta, Inc.
|
|
5,605,129 |
7,832,340 |
|
|
|
2022-04-28 |
13G
|
NSTGQ / NS Wind Down Co., Inc.
|
|
|
3,517,694 |
|
|
|
2022-04-25 |
13G
|
ACRS / Aclaris Therapeutics, Inc.
|
|
0 |
4,398,453 |
|
|
|
2022-04-21 |
13G
|
VERU / Veru Inc.
|
|
|
7,900,000 |
|
|
|
2022-04-08 |
13G
|
ANTX / AN2 Therapeutics, Inc.
|
|
|
3,666,663 |
|
|
|
2022-04-01 |
13D/A
|
KALA / KALA BIO, Inc.
|
|
10,961,533 |
10,914,613 |
|
|
|
2022-03-24 |
13G
|
FLDM / Standard BioTools Inc
|
|
|
4,651,177 |
|
|
|
2022-03-14 |
13D/A
|
CTKB / Cytek Biosciences, Inc.
|
|
11,082,163 |
13,139,327 |
|
|
|
2022-02-28 |
13D/A
|
CTKB / Cytek Biosciences, Inc.
|
|
9,607,028 |
11,082,163 |
|
|
|
2022-02-24 |
13G
|
VERA / Vera Therapeutics, Inc.
|
|
|
2,000,000 |
|
|
|
2022-02-18 |
13G/A
|
SCPH / scPharmaceuticals Inc.
|
|
6,691,770 |
2,691,770 |
|
|
|
2022-02-14 |
13G/A
|
CCXI / ChemoCentryx Inc
|
|
4,776,548 |
0 |
|
|
|
2022-02-14 |
13G/A
|
AVIR / Atea Pharmaceuticals, Inc.
|
|
5,368,451 |
0 |
|
|
|
2022-02-14 |
13G/A
|
KNTE / Kinnate Biopharma Inc.
|
|
3,593,052 |
3,593,052 |
|
|
|
2022-02-14 |
13G/A
|
IMGN / ImmunoGen, Inc.
|
|
18,417,458 |
22,162,958 |
|
|
|
2022-02-14 |
13G/A
|
PHAT / Phathom Pharmaceuticals, Inc.
|
|
3,825,008 |
3,115,008 |
|
|
|
2022-02-14 |
13G/A
|
MCRB / Seres Therapeutics, Inc.
|
|
4,702,206 |
0 |
|
|
|
2022-02-14 |
13G/A
|
ZGNX / Zogenix Inc
|
|
5,345,631 |
3,333,700 |
|
|
|
2022-02-14 |
13G/A
|
CNCE / Concert Pharmaceuticals Inc
|
|
1,823,520 |
3,510,103 |
|
|
|
2022-02-14 |
13G/A
|
CYT / Cyteir Therapeutics, Inc.
|
|
3,247,117 |
3,350,506 |
|
|
|
2022-02-14 |
13G/A
|
VRDN / Viridian Therapeutics, Inc.
|
|
388,385 |
0 |
|
|
|
2022-02-14 |
13G/A
|
FVAM / 5:01 Acquisition Corp.
|
|
750,000 |
750,000 |
|
|
|
2022-02-14 |
13G/A
|
SCPH / scPharmaceuticals Inc.
|
|
3,518,998 |
6,691,770 |
|
|
|
2022-02-14 |
13G/A
|
SBTX / Silverback Therapeutics Inc
|
|
1,742,186 |
1,742,186 |
|
|
|
2022-02-14 |
13G/A
|
XLO / Xilio Therapeutics, Inc.
|
|
1,532,767 |
2,002,217 |
|
|
|
2022-02-14 |
13G/A
|
LRMR / Larimar Therapeutics, Inc.
|
|
1,515,151 |
1,334,610 |
|
|
|
2022-02-14 |
13G/A
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
1,399,489 |
1,930,322 |
|
|
|
2022-02-14 |
13G/A
|
MGNX / MacroGenics, Inc.
|
|
4,375,217 |
6,103,594 |
|
|
|
2022-02-14 |
13G
|
EWTX / Edgewise Therapeutics, Inc.
|
|
|
2,613,623 |
|
|
|
2022-02-14 |
13G/A
|
TNGX / Tango Therapeutics, Inc.
|
|
1,250,000 |
2,250,000 |
|
|
|
2022-02-14 |
13G/A
|
BLSA / BCLS Acquisition Corp - Class A
|
|
1,250,000 |
1,250,000 |
|
|
|
2022-02-14 |
13G/A
|
GHRS / GH Research PLC
|
|
2,978,955 |
2,843,757 |
|
|
|
2022-02-14 |
13G/A
|
OTIC / Otonomy Inc
|
|
3,092,294 |
5,600,000 |
|
|
|
2022-02-14 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
4,557,867 |
5,614,428 |
|
|
|
2022-02-14 |
13G/A
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
41,543,004 |
48,778,172 |
|
|
|
2022-02-14 |
13G/A
|
GERN / Geron Corporation
|
|
31,114,941 |
32,388,799 |
|
|
|
2022-02-14 |
13G/A
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
1,748,021 |
1,136,000 |
|
|
|
2022-02-14 |
13G/A
|
NVAX / Novavax, Inc.
|
|
3,788,564 |
2,097,794 |
|
|
|
2022-02-14 |
13G/A
|
ATXS / Astria Therapeutics, Inc.
|
|
5,745,744 |
1,262,193 |
|
|
|
2022-02-14 |
13G/A
|
MIST / Milestone Pharmaceuticals Inc.
|
|
2,327,714 |
2,246,503 |
|
|
|
2022-02-14 |
13G/A
|
CTMX / CytomX Therapeutics, Inc.
|
|
3,500,000 |
0 |
|
|
|
2022-02-14 |
13G/A
|
AKUS / Akouos Inc
|
|
2,281,249 |
2,281,249 |
|
|
|
2022-02-14 |
13G/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
5,865,338 |
7,567,900 |
|
|
|
2022-02-14 |
13G/A
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
2,150,404 |
2,150,404 |
|
|
|
2022-02-14 |
13G/A
|
DYNE / Dyntek Inc
|
|
2,805,045 |
2,805,045 |
|
|
|
2022-02-14 |
13G/A
|
/ Nautilus Biotechnology Inc
|
|
|
2,436,430 |
|
|
|
2022-02-14 |
13G/A
|
FLAC / Frazier Lifesciences Acquisition Corp - Class A
|
|
|
0 |
|
|
|
2022-02-14 |
13G/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
4,179,067 |
4,871,067 |
|
|
|
2022-02-14 |
13G/A
|
PHAS / PhaseBio Pharmaceuticals Inc
|
|
2,850,000 |
2,850,000 |
|
|
|
2022-02-14 |
13G/A
|
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
|
|
12,315,213 |
9,694,789 |
|
|
|
2022-02-14 |
13G/A
|
PYXS / Pyxis Oncology, Inc.
|
|
1,914,934 |
2,282,173 |
|
|
|
2022-01-10 |
13G
|
PRDS / Pardes Biosciences Inc
|
|
|
4,431,901 |
|
|
|
2021-12-22 |
13G
|
BLU / Bellus Health Inc
|
|
|
10,230,274 |
|
|
|
2021-12-20 |
13G
|
RLMD / Relmada Therapeutics, Inc.
|
|
0 |
2,000,000 |
|
|
|
2021-11-19 |
13G
|
IOBT / IO Biotech, Inc.
|
|
|
1,857,755 |
|
|
|
2021-11-15 |
13G/A
|
ARYD / ARYA Sciences Acquisition Corp IV
|
|
1,000,000 |
0 |
|
|
|
2021-11-15 |
13G/A
|
TRIL / Trillium Therapeutics Inc
|
|
5,290,481 |
0 |
|
|
|
2021-11-15 |
13G/A
|
AADI / Aadi Bioscience, Inc.
|
|
2,486,242 |
0 |
|
|
|
2021-11-15 |
13G
|
/ LIANBIO
|
|
|
7,655,015 |
|
|
|
2021-11-15 |
13G/A
|
CRIS / Curis, Inc.
|
|
7,707,790 |
0 |
|
|
|
2021-11-15 |
13G/A
|
HLXA / Helix Acquisition Corp - Class A
|
|
700,000 |
0 |
|
|
|
2021-11-15 |
13G/A
|
INZY / Inozyme Pharma, Inc.
|
|
2,003,653 |
0 |
|
|
|
2021-11-15 |
13G/A
|
ARDX / Ardelyx, Inc.
|
|
6,163,086 |
0 |
|
|
|
2021-11-12 |
13D/A
|
WVE / Wave Life Sciences Ltd.
|
|
7,823,207 |
7,828,457 |
|
|
|
2021-11-05 |
13G
|
XLO / Xilio Therapeutics, Inc.
|
|
|
1,532,767 |
|
|
|
2021-10-28 |
13D/A
|
FMTX / Forma Therapeutics Holdings Inc
|
|
9,011,651 |
9,029,184 |
|
|
|
2021-10-28 |
13D/A
|
KALA / KALA BIO, Inc.
|
|
10,874,613 |
10,961,533 |
|
|
|
2021-10-25 |
13G
|
OTIC / Otonomy Inc
|
|
|
3,092,294 |
|
|
|
2021-10-25 |
13G
|
PYXS / Pyxis Oncology, Inc.
|
|
|
1,914,934 |
|
|
|
2021-10-01 |
13G
|
SYBX / Synlogic, Inc.
|
|
|
6,666,666 |
|
|
|
2021-09-27 |
13D
|
DICE / DICE Therapeutics Inc
|
|
|
5,208,911 |
|
|
|
2021-09-27 |
13D
|
TYRA / Tyra Biosciences, Inc.
|
|
|
7,236,454 |
|
|
|
2021-09-14 |
13D/A
|
PNT / POINT Biopharma Global Inc.
|
|
8,856,018 |
8,856,018 |
|
|
|
2021-09-13 |
13D/A
|
ABOS / Acumen Pharmaceuticals, Inc.
|
|
9,770,773 |
9,774,551 |
|
|
|
2021-08-23 |
13G
|
AADI / Aadi Bioscience, Inc.
|
|
1,574,806 |
2,486,242 |
|
|
|
2021-08-19 |
13D
|
ELYM / Eliem Therapeutics, Inc.
|
|
|
13,151,959 |
|
|
|
2021-08-18 |
13D/A
|
WVE / Wave Life Sciences Ltd.
|
|
7,775,207 |
7,823,207 |
|
|
|
2021-08-16 |
13G
|
ADVM / Adverum Biotechnologies, Inc.
|
|
9,502,383 |
0 |
|
|
|
2021-08-13 |
13G
|
EYPT / EyePoint Pharmaceuticals, Inc.
|
|
|
1,606,859 |
|
|
|
2021-08-13 |
13G
|
RXST / RxSight, Inc.
|
|
|
3,052,796 |
|
|
|
2021-08-12 |
13D
|
ICVX / Icosavax, Inc.
|
|
|
5,779,347 |
|
|
|
2021-08-09 |
13G
|
DALS / DA32 Life Science Tech Acquisition Corp - Class A
|
|
|
1,500,000 |
|
|
|
2021-08-09 |
13G
|
TNYA / Tenaya Therapeutics, Inc.
|
|
|
3,551,508 |
|
|
|
2021-08-06 |
13D
|
/ Cytek Biosciences, Inc.
|
|
|
9,607,028 |
|
|
|
2021-07-28 |
13G
|
TCRX / TScan Therapeutics, Inc.
|
|
|
1,255,317 |
|
|
|
2021-07-23 |
13G
|
ARYE / ARYA Sciences Acquisition Corp V - Class A
|
|
|
1,000,000 |
|
|
|
2021-07-20 |
13G
|
PNT / POINT Biopharma Global Inc.
|
|
|
8,856,018 |
|
|
|
2021-07-16 |
13D
|
ABOS / Acumen Pharmaceuticals, Inc.
|
|
|
9,770,773 |
|
|
|
2021-07-12 |
13D
|
AVTE / Aerovate Therapeutics, Inc.
|
|
|
8,263,982 |
|
|
|
2021-07-12 |
13G
|
AADI / Aadi Bioscience, Inc.
|
|
|
1,574,806 |
|
|
|
2021-07-09 |
13G
|
GHRS / GH Research PLC
|
|
|
2,978,955 |
|
|
|
2021-06-30 |
13G
|
ENTX / Entera Bio Ltd.
|
|
|
2,353,000 |
|
|
|
2021-06-30 |
13D
|
/ Therapeutics Acquisition Corp. Class A
|
|
|
1,098,318 |
|
|
|
2021-06-29 |
13G
|
CYT / Cyteir Therapeutics, Inc.
|
|
|
3,247,117 |
|
|
|
2021-06-21 |
13G
|
NOVN / Novan Inc
|
|
|
0 |
|
|
|
2021-06-16 |
13D
|
JANX / Janux Therapeutics, Inc.
|
|
|
8,670,644 |
|
|
|
2021-06-16 |
13D/A
|
ETNB / 89bio, Inc.
|
|
4,965,769 |
4,291,881 |
|
|
|
2021-06-15 |
13G
|
ATXS / Astria Therapeutics, Inc.
|
|
|
5,745,744 |
|
|
|
2021-06-07 |
13D/A
|
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
|
|
6,640,417 |
6,991,003 |
|
|
|
2021-06-07 |
13G
|
DAWN / Day One Biopharmaceuticals, Inc.
|
|
|
4,965,588 |
|
|
|
2021-06-04 |
13D/A
|
ETNB / 89bio, Inc.
|
|
4,736,214 |
4,965,769 |
|
|
|
2021-05-27 |
13G
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
786,270 |
1,399,489 |
|
|
|
2021-05-17 |
13G/A
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
4,285,161 |
0 |
|
|
|
2021-05-17 |
13G/A
|
LYRA / Lyra Therapeutics, Inc.
|
|
815,849 |
0 |
|
|
|
2021-05-17 |
13G/A
|
/ Pandion Therapeutics Inc
|
|
1,770,023 |
0 |
|
|
|
2021-05-17 |
13G/A
|
INBX / Inhibrx Biosciences, Inc.
|
|
2,129,003 |
0 |
|
|
|
2021-05-06 |
13D
|
HOWL / Werewolf Therapeutics, Inc.
|
|
|
3,968,583 |
|
|
|
2021-05-05 |
13G
|
MCRB / Seres Therapeutics, Inc.
|
|
|
4,702,206 |
|
|
|
2021-04-16 |
13D
|
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
5,014,687 |
|
|
|
2021-04-07 |
13G/A
|
TRIL / Trillium Therapeutics Inc
|
|
5,290,481 |
5,290,481 |
|
|
|
2021-04-07 |
13G/A
|
AVIR / Atea Pharmaceuticals, Inc.
|
|
5,368,451 |
5,368,451 |
|
|
|
2021-04-07 |
13G
|
BOLT / Bolt Biotherapeutics, Inc.
|
|
|
2,378,325 |
|
|
|
2021-03-30 |
13G/A
|
PCVX / Vaxcyte, Inc.
|
|
3,710,699 |
3,865,808 |
|
|
|
2021-03-29 |
13D
|
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
|
|
|
6,640,417 |
|
|
|
2021-03-24 |
13G
|
PHAS / PhaseBio Pharmaceuticals Inc
|
|
|
2,850,000 |
|
|
|
2021-03-23 |
13D/A
|
SLDB / Solid Biosciences Inc.
|
|
9,976,569 |
12,367,873 |
|
|
|
2021-03-15 |
13G/A
|
VRDN / Viridian Therapeutics, Inc.
|
|
451,932 |
388,385 |
|
|
|
2021-03-09 |
13G
|
ARYD / ARYA Sciences Acquisition Corp IV
|
|
|
1,000,000 |
|
|
|
2021-03-02 |
13D/A
|
859319303 / Sterling Financial Corp
|
|
4,681,858 |
5,914,252 |
|
|
|
2021-02-19 |
13D
|
VOR / Vor Biopharma Inc.
|
|
|
11,120,973 |
|
|
|
2021-02-16 |
13G
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
|
4,285,161 |
|
|
|
2021-02-16 |
13G
|
LYRA / Lyra Therapeutics, Inc.
|
|
|
815,849 |
|
|
|
2021-02-16 |
13G
|
NVAX / Novavax, Inc.
|
|
3,241,083 |
3,788,564 |
|
|
|
2021-02-16 |
13G/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
5,818,862 |
5,865,338 |
|
|
|
2021-02-16 |
13G/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
5,422,312 |
4,179,067 |
|
|
|
2021-02-16 |
13G/A
|
US74140Y1010 / Prevail Therapeutics Inc.
|
|
3,363,605 |
0 |
|
|
|
2021-02-16 |
13G
|
BLSA / BCLS Acquisition Corp - Class A
|
|
|
1,250,000 |
|
|
|
2021-02-16 |
13G
|
IMGN / ImmunoGen, Inc.
|
|
|
18,417,458 |
|
|
|
2021-02-16 |
13G
|
MGNX / MacroGenics, Inc.
|
|
|
4,375,217 |
|
|
|
2021-02-16 |
13G/A
|
PCVX / Vaxcyte, Inc.
|
|
5,489,181 |
3,710,699 |
|
|
|
2021-02-16 |
13G
|
AVIR / Atea Pharmaceuticals, Inc.
|
|
|
5,368,451 |
|
|
|
2021-02-16 |
13G
|
AKUS / Akouos Inc
|
|
|
2,281,249 |
|
|
|
2021-02-16 |
13G
|
CRIS / Curis, Inc.
|
|
|
7,707,790 |
|
|
|
2021-02-16 |
13G
|
INZY / Inozyme Pharma, Inc.
|
|
|
2,003,653 |
|
|
|
2021-02-16 |
13G
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
|
2,150,404 |
|
|
|
2021-02-16 |
13G
|
TRIL / Trillium Therapeutics Inc
|
|
|
5,290,481 |
|
|
|
2021-02-16 |
13G
|
SBTX / Silverback Therapeutics Inc
|
|
|
1,742,186 |
|
|
|
2021-02-16 |
13G
|
FVAM / 5:01 Acquisition Corp.
|
|
|
750,000 |
|
|
|
2021-02-16 |
13G/A
|
CCXI / ChemoCentryx Inc
|
|
3,199,389 |
4,776,548 |
|
|
|
2021-02-16 |
13G/A
|
SCPH / scPharmaceuticals Inc.
|
|
3,247,005 |
3,518,998 |
|
|
|
2021-02-16 |
13G
|
/ Pandion Therapeutics Inc
|
|
|
1,770,023 |
|
|
|
2021-02-16 |
13G
|
KNTE / Kinnate Biopharma Inc.
|
|
|
3,593,052 |
|
|
|
2021-02-16 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
4,252,453 |
4,557,867 |
|
|
|
2021-02-16 |
13G
|
CNCE / Concert Pharmaceuticals Inc
|
|
|
1,823,520 |
|
|
|
2021-02-16 |
13G/A
|
RLMD / Relmada Therapeutics, Inc.
|
|
761,666 |
0 |
|
|
|
2021-02-16 |
13G/A
|
VSTM / Verastem, Inc.
|
|
9,129,251 |
0 |
|
|
|
2021-02-16 |
13G/A
|
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
|
|
10,364,658 |
12,315,213 |
|
|
|
2021-02-16 |
13G
|
GERN / Geron Corporation
|
|
|
31,114,941 |
|
|
|
2021-02-16 |
13G
|
LRMR / Larimar Therapeutics, Inc.
|
|
|
1,515,151 |
|
|
|
2021-02-16 |
13G/A
|
ARDX / Ardelyx, Inc.
|
|
5,527,088 |
6,163,086 |
|
|
|
2021-02-16 |
13G
|
ADVM / Adverum Biotechnologies, Inc.
|
|
|
9,502,383 |
|
|
|
2021-02-16 |
13G/A
|
PHAT / Phathom Pharmaceuticals, Inc.
|
|
3,646,808 |
3,825,008 |
|
|
|
2021-02-16 |
13G
|
HLXA / Helix Acquisition Corp - Class A
|
|
|
700,000 |
|
|
|
2021-02-16 |
13G
|
INBX / Inhibrx Biosciences, Inc.
|
|
|
2,129,003 |
|
|
|
2021-02-16 |
13G
|
NAUT / Nautilus Biotechnology, Inc.
|
|
|
1,000,000 |
|
|
|
2021-02-16 |
13G/A
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
1,648,485 |
1,748,021 |
|
|
|
2021-02-16 |
13G
|
DYNE / Dyntek Inc
|
|
|
2,805,045 |
|
|
|
2021-02-16 |
13G/A
|
ZGNX / Zogenix Inc
|
|
2,260,751 |
5,345,631 |
|
|
|
2021-02-16 |
13G
|
MIST / Milestone Pharmaceuticals Inc.
|
|
|
2,327,714 |
|
|
|
2021-02-16 |
13G/A
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
1,875,209 |
564,102 |
|
|
|
2021-02-16 |
13G
|
TNGX / Tango Therapeutics, Inc.
|
|
|
1,250,000 |
|
|
|
2021-02-16 |
13G
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
|
41,543,004 |
|
|
|
2021-02-11 |
13G/A
|
ITRM / Iterum Therapeutics plc
|
|
13,730,376 |
0 |
|
|
|
2021-02-10 |
13G/A
|
TGTX / TG Therapeutics, Inc.
|
|
12,788,457 |
6,361,123 |
|
|
|
2021-02-10 |
13G/A
|
KROS / Keros Therapeutics, Inc.
|
|
|
0 |
|
|
|
2021-02-10 |
13G/A
|
ARVN / Arvinas, Inc.
|
|
3,672,872 |
0 |
|
|
|
2021-02-10 |
13G/A
|
CRDF / Cardiff Oncology, Inc.
|
|
3,290,000 |
0 |
|
|
|
2021-02-10 |
13G/A
|
TGTX / TG Therapeutics, Inc.
|
|
12,788,457 |
8,685,471 |
|
|
|
2021-02-10 |
13G
|
KROS / Keros Therapeutics, Inc.
|
|
|
1,875,000 |
|
|
|
2021-02-08 |
13G/A
|
ITRM / Iterum Therapeutics plc
|
|
10,000,000 |
13,730,376 |
|
|
|
2021-01-29 |
13G
|
CTMX / CytomX Therapeutics, Inc.
|
|
|
3,500,000 |
|
|
|
2020-12-17 |
13G
|
VRDN / Viridian Therapeutics, Inc.
|
|
|
451,932 |
|
|
|
2020-12-16 |
13D/A
|
SLDB / Solid Biosciences Inc.
|
|
4,571,164 |
9,976,569 |
|
|
|
2020-12-02 |
13G
|
ITRM / Iterum Therapeutics plc
|
|
|
10,000,000 |
|
|
|
2020-10-09 |
13G
|
CRDF / Cardiff Oncology, Inc.
|
|
|
3,290,000 |
|
|
|
2020-10-07 |
13D/A
|
US28249H1041 / Eidos Therapeutics, Inc.
|
|
2,162,671 |
1,798,339 |
|
|
|
2020-09-21 |
13D/A
|
ETNB / 89bio, Inc.
|
|
3,436,214 |
4,736,214 |
|
|
|
2020-09-10 |
13G/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
4,185,342 |
5,818,862 |
|
|
|
2020-08-05 |
13D
|
ITOS / iTeos Therapeutics, Inc.
|
|
|
4,417,259 |
|
|
|
2020-07-24 |
13D
|
NKTX / Nkarta, Inc.
|
|
|
5,605,129 |
|
|
|
2020-07-10 |
13D/A
|
ETNB / 89bio, Inc.
|
|
3,161,214 |
3,436,214 |
|
|
|
2020-07-10 |
13G
|
PCVX / Vaxcyte, Inc.
|
|
|
5,489,181 |
|
|
|
2020-07-10 |
13G/A
|
VSTM / Verastem, Inc.
|
|
18,604,651 |
9,129,251 |
|
|
|
2020-06-25 |
13D
|
FMTX / Forma Therapeutics Holdings Inc
|
|
|
9,011,651 |
|
|
|
2020-06-10 |
13G/A
|
TGTX / TG Therapeutics, Inc.
|
|
9,880,323 |
12,788,457 |
|
|
|
2020-04-09 |
13G/A
|
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
|
|
6,389,901 |
10,364,658 |
|
|
|
2020-03-13 |
13D/A
|
KALA / KALA BIO, Inc.
|
|
4,537,478 |
10,874,613 |
|
|
|
2020-03-05 |
13G
|
VSTM / Verastem, Inc.
|
|
|
18,604,651 |
|
|
|
2020-02-14 |
13G/A
|
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
|
|
4,845,933 |
6,389,901 |
|
|
|
2020-02-14 |
13G/A
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
10,660,349 |
0 |
|
|
|
2020-02-14 |
13G
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
|
1,648,485 |
|
|
|
2020-02-14 |
13G/A
|
EIGR / Eiger BioPharmaceuticals, Inc.
|
|
2,415,458 |
0 |
|
|
|
2020-02-14 |
13G
|
CCXI / ChemoCentryx Inc
|
|
|
3,199,389 |
|
|
|
2020-02-14 |
13G/A
|
TGTX / TG Therapeutics, Inc.
|
|
8,198,337 |
9,880,323 |
|
|
|
2020-02-14 |
13G
|
ARDX / Ardelyx, Inc.
|
|
2,103,530 |
5,527,088 |
|
|
|
2020-02-14 |
13G
|
RLMD / Relmada Therapeutics, Inc.
|
|
|
761,666 |
|
|
|
2020-02-14 |
13G/A
|
SCPH / scPharmaceuticals Inc.
|
|
2,857,143 |
3,247,005 |
|
|
|
2020-02-14 |
13G/A
|
ARVN / Arvinas, Inc.
|
|
|
3,672,872 |
|
|
|
2020-02-14 |
13G/A
|
MYOV / Myovant Sciences Ltd
|
|
3,711,549 |
0 |
|
|
|
2020-02-14 |
13G/A
|
PHAT / Phathom Pharmaceuticals, Inc.
|
|
3,646,646 |
3,646,808 |
|
|
|
2020-02-14 |
13G/A
|
ZGNX / Zogenix Inc
|
|
2,382,168 |
2,260,751 |
|
|
|
2020-02-14 |
13G
|
TVTX / Travere Therapeutics, Inc.
|
|
|
4,252,453 |
|
|
|
2020-02-14 |
13G/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
4,240,536 |
4,185,342 |
|
|
|
2020-02-14 |
13G
|
US74140Y1010 / Prevail Therapeutics Inc.
|
|
|
3,363,605 |
|
|
|
2020-02-05 |
13D
|
BDTX / Black Diamond Therapeutics, Inc.
|
|
|
2,589,904 |
|
|
|
2019-11-13 |
13D
|
ETNB / 89bio, Inc.
|
|
|
3,161,214 |
|
|
|
2019-11-08 |
13G
|
PHAT / Phathom Pharmaceuticals, Inc.
|
|
|
3,646,646 |
|
|
|
2019-10-18 |
13G/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
1,950,332 |
5,422,312 |
|
|
|
2019-10-11 |
13D/A
|
RARX / Ra Pharmaceuticals, Inc.
|
|
3,851,808 |
4,858,260 |
|
|
|
2019-09-17 |
13D
|
859319303 / Sterling Financial Corp
|
|
|
4,681,858 |
|
|
|
2019-07-30 |
13D/A
|
SLDB / Solid Biosciences Inc.
|
|
|
4,571,164 |
|
|
|
2019-07-10 |
13G/A
|
IFRX / InflaRx N.V.
|
|
2,810,708 |
0 |
|
|
|
2019-04-24 |
13D/A
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
958,570 |
786,270 |
|
|
|
2019-04-15 |
13D/A
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
1,441,070 |
958,570 |
|
|
|
2019-04-10 |
13G/A
|
IFRX / InflaRx N.V.
|
|
2,085,089 |
2,810,708 |
|
|
|
2019-02-14 |
13G/A
|
SPRO / Spero Therapeutics, Inc.
|
|
|
0 |
|
|
|
2019-02-14 |
13G/A
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
9,234,692 |
10,660,349 |
|
|
|
2019-02-14 |
13G/A
|
KDMN / Kadmon Holdings Inc
|
|
80,293,421 |
2,666,666 |
|
|
|
2019-02-14 |
13G/A
|
BHVN / Biohaven Ltd.
|
|
1,997,278 |
0 |
|
|
|
2019-02-14 |
13G/A
|
IFRX / InflaRx N.V.
|
|
1,620,653 |
2,085,089 |
|
|
|
2019-02-14 |
13G/A
|
KRYS / Krystal Biotech, Inc.
|
|
700,000 |
0 |
|
|
|
2019-02-14 |
13G
|
ZGNX / Zogenix Inc
|
|
1,145,268 |
2,382,168 |
|
|
|
2019-02-14 |
13G
|
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
4,845,933 |
|
|
|
2019-02-14 |
13G
|
TGTX / TG Therapeutics, Inc.
|
|
1,004,314 |
8,198,337 |
|
|
|
2019-02-14 |
13G
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
|
1,950,332 |
|
|
|
2019-02-14 |
13G
|
ARVN / Arvinas, Inc.
|
|
|
3,138,412 |
|
|
|
2019-02-14 |
13G
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
|
1,875,209 |
|
|
|
2019-02-14 |
13G
|
MYOV / Myovant Sciences Ltd
|
|
|
3,711,549 |
|
|
|
2019-02-11 |
13G/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
5,580,690 |
4,240,536 |
|
|
|
2019-01-28 |
13D/A
|
WVE / Wave Life Sciences Ltd.
|
|
7,512,049 |
7,775,207 |
|
|
|
2018-11-07 |
13D/A
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
3,324,989 |
2,814,589 |
|
|
|
2018-11-02 |
13D/A
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
3,324,989 |
3,324,989 |
|
|
|
2018-11-01 |
13D/A
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
3,933,489 |
3,324,989 |
|
|
|
2018-10-25 |
13G
|
EIGR / Eiger BioPharmaceuticals, Inc.
|
|
|
2,415,458 |
|
|
|
2018-10-05 |
13D/A
|
KALA / KALA BIO, Inc.
|
|
2,113,236 |
4,537,478 |
|
|
|
2018-08-06 |
13G/A
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
6,984,692 |
9,234,692 |
|
|
|
2018-07-10 |
13G/A
|
867328601 / Sunesis Pharmaceuticals, Inc.
|
|
35,968,401 |
500,000 |
|
|
|
2018-07-02 |
13D
|
US28249H1041 / Eidos Therapeutics, Inc.
|
|
|
2,162,671 |
|
|
|
2018-04-26 |
13G/A
|
IFRX / InflaRx N.V.
|
|
|
1,620,653 |
|
|
|
2018-04-02 |
13D
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
6,984,692 |
6,984,692 |
|
|
|
2018-03-27 |
13D/A
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
4,462,313 |
3,933,489 |
|
|
|
2018-02-16 |
13D/A
|
RARX / Ra Pharmaceuticals, Inc.
|
|
1,351,808 |
3,851,808 |
|
|
|
2018-02-14 |
13G
|
SPRO / Spero Therapeutics, Inc.
|
|
|
1,225,647 |
|
|
|
2018-02-14 |
13G
|
KDMN / Kadmon Holdings Inc
|
|
|
8,029,342 |
|
|
|
2018-02-14 |
13G
|
TARA / Protara Therapeutics, Inc.
|
|
0 |
1,679,205 |
|
|
|
2018-02-14 |
13G
|
KRYS / Krystal Biotech, Inc.
|
|
|
700,000 |
|
|
|
2018-02-14 |
13G
|
BHVN / Biohaven Ltd.
|
|
|
1,997,278 |
|
|
|
2018-02-14 |
13G
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
3,094,064 |
6,984,692 |
|
|
|
2018-02-14 |
13G/A
|
ABIO / ARCA biopharma, Inc.
|
|
5,567,351 |
324,490 |
|
|
|
2018-02-14 |
13G/A
|
AVXS / AveXis, Inc.
|
|
1,890,796 |
1,171,278 |
|
|
|
2018-02-14 |
13G/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
2,191,977 |
0 |
|
|
|
2018-02-14 |
13G/A
|
SBBP / Strongbridge Biopharma plc
|
|
2,279,099 |
0 |
|
|
|
2018-02-14 |
13G/A
|
TENX / Tenax Therapeutics, Inc.
|
|
2,389,700 |
0 |
|
|
|
2018-02-14 |
13G/A
|
ZGNX / Zogenix Inc
|
|
2,451,237 |
1,145,268 |
|
|
|
2018-02-14 |
13G/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
5,409,990 |
5,580,690 |
|
|
|
2018-02-14 |
13D
|
KALA / KALA BIO, Inc.
|
|
|
2,113,236 |
|
|
|
2018-02-14 |
13G
|
ECYT / Endocyte, Inc.
|
|
|
3,364,648 |
|
|
|
2018-02-14 |
13G/A
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
13,633,220 |
585,890 |
|
|
|
2018-02-09 |
13D
|
SLDB / Solid Biosciences Inc.
|
|
|
2,689,444 |
|
|
|
2018-01-19 |
13D/A
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
5,074,013 |
4,462,313 |
|
|
|
2017-12-20 |
13D/A
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
4,588,536 |
5,074,013 |
|
|
|
2017-12-15 |
13D/A
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
4,588,536 |
4,588,536 |
|
|
|
2017-12-11 |
13G
|
IFRX / InflaRx N.V.
|
|
|
2,876,080 |
|
|
|
2017-12-11 |
13G
|
SCPH / scPharmaceuticals Inc.
|
|
|
2,857,143 |
|
|
|
2017-11-15 |
13D/A
|
WVE / Wave Life Sciences Ltd.
|
|
7,088,651 |
7,512,049 |
|
|
|
2017-11-13 |
13D/A
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
591,070 |
1,441,070 |
|
|
|
2017-11-13 |
13G
|
867328601 / Sunesis Pharmaceuticals, Inc.
|
|
|
3,596,840 |
|
|
|
2017-04-13 |
13D/A
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
|
4,588,536 |
|
|
|
2017-02-15 |
13G/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
5,378,716 |
5,409,990 |
|
|
|
2017-02-15 |
13G/A
|
SNWV / SANUWAVE Health, Inc.
|
|
|
0 |
|
|
|
2017-02-15 |
13G/A
|
TGTX / TG Therapeutics, Inc.
|
|
2,813,779 |
1,004,314 |
|
|
|
2017-02-15 |
13G/A
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
11,222,893 |
13,633,220 |
|
|
|
2017-02-15 |
13G/A
|
PTGX / Protagonist Therapeutics, Inc.
|
|
1,109,229 |
692,563 |
|
|
|
2017-02-15 |
13G/A
|
SBBP / Strongbridge Biopharma plc
|
|
2,690,702 |
2,279,099 |
|
|
|
2017-02-15 |
13G/A
|
DSCI / Derma Sciences, Inc.
|
|
2,055,676 |
0 |
|
|
|
2017-02-15 |
13G/A
|
TENX / Tenax Therapeutics, Inc.
|
|
2,389,700 |
2,389,700 |
|
|
|
2017-02-15 |
13G/A
|
ZGNX / Zogenix Inc
|
|
2,253,237 |
2,451,237 |
|
|
|
2017-02-15 |
13G/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
1,619,977 |
2,191,977 |
|
|
|
2017-02-15 |
13G/A
|
ZYNE / Zynerba Pharmaceuticals Inc
|
|
507,191 |
0 |
|
|
|
2017-02-15 |
13G/A
|
ARDX / Ardelyx, Inc.
|
|
3,625,943 |
2,103,530 |
|
|
|
2017-02-15 |
13G/A
|
RGLS / Regulus Therapeutics Inc.
|
|
3,482,924 |
0 |
|
|
|
2017-02-15 |
13G/A
|
ACRS / Aclaris Therapeutics, Inc.
|
|
1,530,020 |
0 |
|
|
|
2017-02-15 |
13G/A
|
CDTX / Cidara Therapeutics, Inc.
|
|
1,174,219 |
0 |
|
|
|
2017-02-15 |
13G/A
|
TARA / Protara Therapeutics, Inc.
|
|
1,476,931 |
0 |
|
|
|
2017-02-14 |
13D
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
|
591,070 |
|
|
|
2017-02-14 |
13G/A
|
ABIO / ARCA biopharma, Inc.
|
|
928,195 |
556,735 |
|
|
|
2017-02-14 |
13G/A
|
AVXS / AveXis, Inc.
|
|
1,890,796 |
1,890,796 |
|
|
|
2017-02-14 |
13G/A
|
SIOX / Sio Gene Therapies Inc.
|
|
5,000,000 |
0 |
|
|
|
2016-12-23 |
13G
|
AVXS / AveXis, Inc.
|
|
|
1,890,796 |
|
|
|
2016-12-06 |
13G/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
2,927,857 |
5,378,716 |
|
|
|
2016-11-09 |
13D
|
RARX / Ra Pharmaceuticals, Inc.
|
|
|
1,351,808 |
|
|
|
2016-10-21 |
13G/A
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
3,032,911 |
1,308,234 |
|
|
|
2016-10-06 |
13G/A
|
ACRS / Aclaris Therapeutics, Inc.
|
|
2,564,553 |
1,530,020 |
|
|
|
2016-08-25 |
13G
|
PTGX / Protagonist Therapeutics, Inc.
|
|
|
1,109,229 |
|
|
|
2016-08-15 |
13G
|
VTAE / Vitae Pharmaceuticals, Inc.
|
|
|
2,119,036 |
|
|
|
2016-07-28 |
13G
|
ARDX / Ardelyx, Inc.
|
|
739,669 |
3,625,943 |
|
|
|
2016-06-07 |
13G/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
1,671,447 |
2,927,857 |
|
|
|
2016-02-16 |
13G/A
|
BPMC / Blueprint Medicines Corporation
|
|
|
878,348 |
|
|
|
2016-02-16 |
13G/A
|
TRVN / Trevena, Inc.
|
|
|
0 |
|
|
|
2016-02-16 |
13G/A
|
ARDX / Ardelyx, Inc.
|
|
1,897,620 |
739,669 |
|
|
|
2016-02-16 |
13G/A
|
ABUS / Arbutus Biopharma Corporation
|
|
|
0 |
|
|
|
2016-02-16 |
13G/A
|
RGLS / Regulus Therapeutics Inc.
|
|
|
3,482,924 |
|
|
|
2016-02-16 |
13G/A
|
ACRS / Aclaris Therapeutics, Inc.
|
|
2,237,130 |
2,564,553 |
|
|
|
2016-02-16 |
13G/A
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
3,092,595 |
618,519 |
|
|
|
2016-02-16 |
13G/A
|
CDTX / Cidara Therapeutics, Inc.
|
|
1,488,248 |
1,174,219 |
|
|
|
2016-02-16 |
13G/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
1,428,776 |
1,671,447 |
|
|
|
2016-02-16 |
13G/A
|
ZYNE / Zynerba Pharmaceuticals Inc
|
|
578,575 |
507,191 |
|
|
|
2016-02-16 |
13G
|
SIOX / Sio Gene Therapies Inc.
|
|
|
5,000,000 |
|
|
|
2016-02-16 |
13G/A
|
TENX / Tenax Therapeutics, Inc.
|
|
|
2,389,700 |
|
|
|
2016-02-16 |
13G/A
|
BBI / Brickell Biotech Inc
|
|
|
0 |
|
|
|
2016-02-16 |
13G/A
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
3,094,064 |
|
|
|
2016-02-16 |
13G/A
|
ABIO / ARCA biopharma, Inc.
|
|
5,678,592 |
928,195 |
|
|
|
2016-02-16 |
13G/A
|
ARMP / Armata Pharmaceuticals, Inc.
|
|
|
365,393 |
|
|
|
2016-02-16 |
13G/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
1,032,151 |
1,619,977 |
|
|
|
2016-02-16 |
13G/A
|
ZGNX / Zogenix Inc
|
|
1,840,716 |
2,253,237 |
|
|
|
2016-02-16 |
13G/A
|
WGBS / WaferGen Bio-Systems, Inc.
|
|
0 |
560,000 |
|
|
|
2016-02-16 |
13G/A
|
TARA / Protara Therapeutics, Inc.
|
|
|
1,476,931 |
|
|
|
2016-02-16 |
13G/A
|
XNCR / Xencor, Inc.
|
|
3,156,844 |
0 |
|
|
|
2016-02-16 |
13G/A
|
COLL / Collegium Pharmaceutical, Inc.
|
|
1,545,410 |
857,683 |
|
|
|
2016-02-16 |
13G/A
|
AGRX / Agile Therapeutics, Inc.
|
|
|
0 |
|
|
|
2016-02-16 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
|
0 |
|
|
|
2016-02-16 |
13G/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
2,496,178 |
0 |
|
|
|
2016-02-16 |
13G/A
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
11,222,893 |
|
|
|
2016-02-16 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
|
0 |
|
|
|
2016-02-16 |
13G/A
|
TGTX / TG Therapeutics, Inc.
|
|
|
2,813,779 |
|
|
|
2016-01-29 |
13G
|
DSCI / Derma Sciences, Inc.
|
|
|
2,055,676 |
|
|
|
2015-11-27 |
13D
|
WVE / Wave Life Sciences Ltd.
|
|
|
7,088,651 |
|
|
|
2015-11-18 |
13G/A
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
1,660,594 |
3,032,911 |
|
|
|
2015-10-26 |
13G
|
SBBP / Strongbridge Biopharma plc
|
|
|
2,690,702 |
|
|
|
2015-10-14 |
13G
|
ZYNE / Zynerba Pharmaceuticals Inc
|
|
|
578,575 |
|
|
|
2015-10-13 |
13G
|
ACRS / Aclaris Therapeutics, Inc.
|
|
|
2,237,130 |
|
|
|
2015-10-08 |
13G
|
ZGNX / Zogenix Inc
|
|
|
1,840,716 |
|
|
|
2015-09-29 |
13G/A
|
SGMO / Sangamo Therapeutics, Inc.
|
|
|
1,220,209 |
|
|
|
2015-08-24 |
13G
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
|
1,032,151 |
|
|
|
2015-07-07 |
13G
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
|
1,660,594 |
|
|
|
2015-06-25 |
13G
|
ABIO / ARCA biopharma, Inc.
|
|
|
5,678,592 |
|
|
|
2015-06-05 |
13G
|
ARDX / Ardelyx, Inc.
|
|
|
1,897,620 |
|
|
|
2015-05-15 |
13G
|
COLL / Collegium Pharmaceutical, Inc.
|
|
|
1,545,410 |
|
|
|
2015-05-14 |
13G
|
XNCR / Xencor, Inc.
|
|
|
3,156,844 |
|
|
|
2015-05-08 |
13G
|
BPMC / Blueprint Medicines Corporation
|
|
|
1,488,248 |
|
|
|
2015-05-08 |
13G
|
CDTX / Cidara Therapeutics, Inc.
|
|
967,858 |
1,488,248 |
|
|
|
2015-05-08 |
13G
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
1,428,776 |
|
|
|
2015-04-21 |
13G
|
CDTX / Cidara Therapeutics, Inc.
|
|
|
967,858 |
|
|
|
2015-04-03 |
13G/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
2,496,178 |
|
|
|
2015-03-25 |
13G
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
|
3,092,595 |
|
|
|
2015-02-19 |
13G/A
|
SGMO / Sangamo Therapeutics, Inc.
|
|
|
2,731,389 |
|
|
|
2015-02-17 |
13G/A
|
OCRX / Ocera Therapeutics, Inc.
|
|
|
523,035 |
|
|
|
2015-02-17 |
13G/A
|
PSDV / pSivida Corp.
|
|
|
0 |
|
|
|
2015-02-17 |
13G/A
|
TRVN / Trevena, Inc.
|
|
|
2,974,647 |
|
|
|
2015-02-17 |
13G/A
|
SNWV / SANUWAVE Health, Inc.
|
|
|
5,019,945 |
|
|
|
2015-02-17 |
13G/A
|
TENX / Tenax Therapeutics, Inc.
|
|
|
2,670,300 |
|
|
|
2015-02-17 |
13G/A
|
ARAV / Aravive, Inc.
|
|
|
231,267 |
|
|
|
2015-02-17 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
|
840,000 |
|
|
|
2015-02-17 |
13G/A
|
WGBS / WaferGen Bio-Systems, Inc.
|
|
|
560,000 |
|
|
|
2015-02-17 |
13G/A
|
ENTA / Enanta Pharmaceuticals, Inc.
|
|
|
0 |
|
|
|
2015-02-17 |
13G/A
|
76028H209 / Repros Therapeutics, Inc.
|
|
|
0 |
|
|
|
2015-02-17 |
13G/A
|
APHB / Ampliphi Biosciences Corp.
|
|
|
26,785,712 |
|
|
|
2015-02-17 |
13G/A
|
ENZ / Enzo Biochem, Inc.
|
|
|
0 |
|
|
|
2015-02-17 |
13G/A
|
ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
|
0 |
|
|
|
2015-02-17 |
13G/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
165,516 |
|
|
|
2015-02-17 |
13G/A
|
PRTA / Prothena Corporation plc
|
|
|
0 |
|
|
|
2015-02-17 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
|
2,603,044 |
|
|
|
2015-02-17 |
13G/A
|
TNGNQ / Tengion, Inc.
|
|
|
3,984,267 |
|
|
|
2015-02-17 |
13G/A
|
RGLS / Regulus Therapeutics Inc.
|
|
|
4,742,911 |
|
|
|
2015-02-17 |
13G/A
|
BBI / Brickell Biotech Inc
|
|
|
6,203,690 |
|
|
|
2015-02-17 |
13G/A
|
FURX / Furiex Pharmaceuticals, Inc.
|
|
|
0 |
|
|
|
2015-02-17 |
13G/A
|
TGTX / TG Therapeutics, Inc.
|
|
|
3,350,449 |
|
|
|
2015-02-17 |
13G/A
|
VIRX / Viracta Therapeutics, Inc.
|
|
|
0 |
|
|
|
2015-02-17 |
13G/A
|
TARA / Protara Therapeutics, Inc.
|
|
|
1,250,000 |
|
|
|
2015-02-17 |
13G/A
|
NVAX / Novavax, Inc.
|
|
|
3,241,083 |
|
|
|
2015-02-17 |
13G/A
|
TXMD / TherapeuticsMD, Inc.
|
|
|
3,211,132 |
|
|
|
2015-02-17 |
13G/A
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
7,050,356 |
|
|
|
2015-02-17 |
13G/A
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
9,200,000 |
|
|
|
2015-02-17 |
13G/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
1,027,300 |
|
|
|
2015-02-17 |
13G/A
|
SGMO / Sangamo Therapeutics, Inc.
|
|
|
7,220,209 |
|
|
|
2015-02-17 |
13G/A
|
DSCI / Derma Sciences, Inc.
|
|
|
363,636 |
|
|
|
2015-02-17 |
13G/A
|
DYAX / Dyax Corp.
|
|
|
4,945,697 |
|
|
|
2015-01-30 |
13G
|
AGRX / Agile Therapeutics, Inc.
|
|
|
1,458,792 |
|
|
|
2015-01-20 |
13G
|
ABUS / Arbutus Biopharma Corporation
|
|
|
2,214,800 |
|
|
|
2015-01-20 |
13D/A
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
19,957,061 |
|
|
|
2015-01-20 |
13G/A
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
7,091,103 |
|
|
|
2014-12-12 |
13G
|
TRVN / Trevena, Inc.
|
|
|
2,974,647 |
|
|
|
2014-11-07 |
13G
|
RGLS / Regulus Therapeutics Inc.
|
|
|
4,742,911 |
|
|
|
2014-10-31 |
13G
|
TARA / Protara Therapeutics, Inc.
|
|
|
1,250,000 |
|
|
|
2014-10-17 |
13G
|
TGTX / TG Therapeutics, Inc.
|
|
|
3,145,571 |
|
|
|
2014-09-26 |
13G
|
TENX / Tenax Therapeutics, Inc.
|
|
|
2,264,528 |
|
|
|
2014-09-26 |
13G/A
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
11,032,014 |
|
|
|
2014-09-02 |
13G
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
17,704,362 |
|
|
|
2014-08-29 |
13G
|
WGBS / WaferGen Bio-Systems, Inc.
|
|
|
560,000 |
|
|
|
2014-08-27 |
13D/A
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
18,539,655 |
|
|
|
2014-08-20 |
13D/A
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
21,251,007 |
|
|
|
2014-08-19 |
13G
|
BBI / Brickell Biotech Inc
|
|
|
5,475,419 |
|
|
|
2014-06-24 |
13D/A
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
22,486,007 |
|
|
|
2014-05-08 |
13G
|
SCYX / SCYNEXIS, Inc.
|
|
|
840,000 |
|
|
|
2014-05-02 |
13G
|
DYAX / Dyax Corp.
|
|
|
9,015,230 |
|
|
|
2014-04-09 |
13G
|
ARAV / Aravive, Inc.
|
|
|
1,404,688 |
|
|
|
2014-04-01 |
13G
|
ENTA / Enanta Pharmaceuticals, Inc.
|
|
|
1,541,078 |
|
|
|
2014-03-24 |
13G
|
PSDV / pSivida Corp.
|
|
|
2,555,659 |
|
|
|
2014-03-24 |
13G
|
SNWV / SANUWAVE Health, Inc.
|
|
|
4,674,972 |
|
|
|
2014-03-21 |
13D/A
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
23,366,007 |
|
|
|
2014-03-21 |
13G/A
|
DSCI / Derma Sciences, Inc.
|
|
|
1,953,071 |
|
|
|
2014-03-21 |
13G
|
APHB / Ampliphi Biosciences Corp.
|
|
|
26,785,712 |
|
|
|
2014-03-18 |
13G
|
76028H209 / Repros Therapeutics, Inc.
|
|
|
1,439,048 |
|
|
|
2014-02-14 |
13G/A
|
KERX / Keryx Biopharmaceuticals, Inc.
|
|
|
0 |
|
|
|
2014-02-14 |
13G/A
|
SSKN / STRATA Skin Sciences, Inc.
|
|
|
0 |
|
|
|
2014-02-14 |
13G/A
|
LUMO / Lumos Pharma, Inc.
|
|
|
0 |
|
|
|
2014-02-14 |
13G/A
|
OMER / Omeros Corporation
|
|
|
0 |
|
|
|
2014-02-14 |
13G/A
|
TNGNQ / Tengion, Inc.
|
|
|
948,856 |
|
|
|
2014-02-14 |
13G/A
|
INSM / Insmed Incorporated
|
|
|
0 |
|
|
|
2014-02-14 |
13G/A
|
MEIP / MEI Pharma, Inc.
|
|
|
816,666 |
|
|
|
2014-02-14 |
13G/A
|
NVAX / Novavax, Inc.
|
|
|
10,811,888 |
|
|
|
2014-02-14 |
13G/A
|
SNMX / Senomyx, Inc.
|
|
|
0 |
|
|
|
2014-02-14 |
13G/A
|
VIRX / Viracta Therapeutics, Inc.
|
|
|
4,869,261 |
|
|
|
2014-02-14 |
13G/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
1,169,898 |
|
|
|
2014-02-14 |
13G/A
|
SGMO / Sangamo Therapeutics, Inc.
|
|
|
5,227,272 |
|
|
|
2014-02-14 |
13G/A
|
OCRX / Ocera Therapeutics, Inc.
|
|
|
767,255 |
|
|
|
2014-02-14 |
13G/A
|
CCXI / ChemoCentryx Inc
|
|
|
0 |
|
|
|
2014-02-14 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
|
25,999,886 |
|
|
|
2014-02-14 |
13G/A
|
HPTX / Hyperion Therapeutics Inc
|
|
|
0 |
|
|
|
2014-02-14 |
13G/A
|
FBIO / Fortress Biotech, Inc.
|
|
|
0 |
|
|
|
2014-02-14 |
13G/A
|
PRTA / Prothena Corporation plc
|
|
|
1,641,167 |
|
|
|
2014-02-14 |
13G
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
822,284 |
|
|
|
2014-02-14 |
13G
|
TXMD / TherapeuticsMD, Inc.
|
|
|
11,660,108 |
|
|
|
2014-02-14 |
13G/A
|
ENZ / Enzo Biochem, Inc.
|
|
|
2,268,653 |
|
|
|
2014-02-14 |
13G/A
|
XOMA / XOMA Royalty Corporation
|
|
|
687,879 |
|
|
|
2014-02-14 |
13G/A
|
ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
|
3,929,016 |
|
|
|
2014-02-14 |
13G/A
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
4,347,456 |
|
|
|
2014-02-14 |
13G/A
|
DSCI / Derma Sciences, Inc.
|
|
|
1,589,435 |
|
|
|
2014-02-14 |
13G/A
|
DYAX / Dyax Corp.
|
|
|
5,761,497 |
|
|
|
2014-02-14 |
13G/A
|
ACHV / Achieve Life Sciences, Inc.
|
|
|
0 |
|
|
|
2014-02-05 |
13D
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
|
2,428,571 |
|
|
|
2014-02-05 |
13G
|
FURX / Furiex Pharmaceuticals, Inc.
|
|
|
750,000 |
|
|
|
2013-12-10 |
13G
|
XNCR / Xencor, Inc.
|
|
|
2,725,000 |
|
|
|
2013-11-14 |
13G/A
|
ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
|
3,653,992 |
|
|
|
2013-11-05 |
13G
|
DVAX / Dynavax Technologies Corporation
|
|
|
25,993,234 |
|
|
|
2013-11-01 |
13D
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
20,461,007 |
|
|
|
2013-10-04 |
13G
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
14,457,061 |
|
|
|
2013-09-13 |
13G
|
CCXI / ChemoCentryx Inc
|
|
|
3,045,380 |
|
|
|
2013-08-27 |
13G
|
PRTA / Prothena Corporation plc
|
|
|
1,648,599 |
|
|
|
2013-08-09 |
13G
|
ENZ / Enzo Biochem, Inc.
|
|
|
3,348,029 |
|
|
|
2013-08-09 |
13G
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
5,850,000 |
|
|
|
2013-07-12 |
13G
|
TNGNQ / Tengion, Inc.
|
|
|
414,198 |
|
|
|
2013-05-20 |
13G
|
OMER / Omeros Corporation
|
|
|
2,953,004 |
|
|
|
2013-05-09 |
13G
|
ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
|
3,127,401 |
|
|
|
2013-05-08 |
13G
|
OCRX / Ocera Therapeutics, Inc.
|
|
|
2,700,000 |
|
|
|
2013-05-01 |
13G/A
|
DSCI / Derma Sciences, Inc.
|
|
|
1,994,876 |
|
|
|
2013-03-04 |
13G
|
HPTX / Hyperion Therapeutics Inc
|
|
|
866,088 |
|
|
|
2013-02-15 |
13G
|
SSKN / STRATA Skin Sciences, Inc.
|
|
|
2,992,608 |
|
|
|
2013-02-15 |
13G
|
KERX / Keryx Biopharmaceuticals, Inc.
|
|
|
5,285,000 |
|
|
|
2013-02-15 |
13G
|
LUMO / Lumos Pharma, Inc.
|
|
|
1,576,981 |
|
|
|
2013-02-14 |
13G/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
7,347,878 |
|
|
|
2013-02-14 |
13G/A
|
ANTH / Anthera Pharmaceuticals, Inc.
|
|
|
0 |
|
|
|
2013-02-14 |
13G/A
|
ECYT / Endocyte, Inc.
|
|
|
0 |
|
|
|
2013-02-14 |
13G/A
|
MEIP / MEI Pharma, Inc.
|
|
|
991,666 |
|
|
|
2013-02-14 |
13G/A
|
INSM / Insmed Incorporated
|
|
|
2,433,319 |
|
|
|
2013-02-14 |
13G/A
|
NVAX / Novavax, Inc.
|
|
|
14,411,748 |
|
|
|
2013-02-14 |
13G/A
|
POZN / Pozen, Inc.
|
|
|
0 |
|
|
|
2013-02-14 |
13G/A
|
SNMX / Senomyx, Inc.
|
|
|
3,965,635 |
|
|
|
2013-02-14 |
13G/A
|
SGMO / Sangamo Therapeutics, Inc.
|
|
|
3,835,776 |
|
|
|
2013-02-14 |
13G/A
|
VIRX / Viracta Therapeutics, Inc.
|
|
|
4,887,230 |
|
|
|
2013-02-14 |
13G/A
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
|
0 |
|
|
|
2013-02-14 |
13G/A
|
032420101 / Anacor Pharmaceuticals, Inc.
|
|
|
0 |
|
|
|
2013-02-14 |
13G/A
|
ASMB / Assembly Biosciences, Inc.
|
|
|
628,092 |
|
|
|
2013-02-14 |
13G/A
|
FBIO / Fortress Biotech, Inc.
|
|
|
1,735,597 |
|
|
|
2013-02-14 |
13G/A
|
XOMA / XOMA Royalty Corporation
|
|
|
6,698,558 |
|
|
|
2013-02-14 |
13G/A
|
|
|
|
662,117,262 |
|
|
|
2013-02-14 |
13G/A
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
0 |
|
|
|
2013-02-14 |
13G/A
|
UPI / Uroplasty Inc
|
|
|
0 |
|
|
|
2013-02-14 |
13G/A
|
DSCI / Derma Sciences, Inc.
|
|
|
1,599,332 |
|
|
|
2013-02-14 |
13G/A
|
DYAX / Dyax Corp.
|
|
|
8,528,440 |
|
|
|
2013-02-14 |
13G/A
|
ACHV / Achieve Life Sciences, Inc.
|
|
|
894,232 |
|
|
|
2013-01-03 |
13G
|
MEIP / MEI Pharma, Inc.
|
|
|
991,666 |
|
|
|
2012-11-13 |
13G
|
SGMO / Sangamo Therapeutics, Inc.
|
|
|
2,918,163 |
|
|
|
2012-10-03 |
13G
|
INSM / Insmed Incorporated
|
|
|
2,459,039 |
|
|
|
2012-09-26 |
13G
|
VIRX / Viracta Therapeutics, Inc.
|
|
|
2,538,846 |
|
|
|
2012-08-30 |
13G
|
SNMX / Senomyx, Inc.
|
|
|
2,757,076 |
|
|
|
2012-07-27 |
13G
|
ANTH / Anthera Pharmaceuticals, Inc.
|
|
|
4,500,000 |
|
|
|
2012-07-03 |
13G
|
032420101 / Anacor Pharmaceuticals, Inc.
|
|
|
2,405,177 |
|
|
|
2012-07-03 |
13G
|
ASMB / Assembly Biosciences, Inc.
|
|
|
1,245,000 |
|
|
|
2012-07-03 |
13G
|
FBIO / Fortress Biotech, Inc.
|
|
|
1,775,154 |
|
|
|
2012-05-22 |
13G
|
NVAX / Novavax, Inc.
|
|
|
13,200,000 |
|
|
|
2012-03-20 |
13G
|
UPI / Uroplasty Inc
|
|
|
1,235,100 |
|
|
|
2012-03-16 |
13G
|
XOMA / XOMA Royalty Corporation
|
|
|
5,698,809 |
|
|
|
2012-03-16 |
13G
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
3,008,433 |
|
|
|
2012-02-17 |
13G/A
|
GEVA / Synageva Biopharma Corp
|
|
|
181,499 |
|
|
|
2012-02-14 |
13G/A
|
878193101 / TearLab Corp
|
|
|
1,020,545 |
|
|
|
2012-02-14 |
13G/A
|
ECYT / Endocyte, Inc.
|
|
|
2,530,679 |
|
|
|
2012-02-14 |
13G/A
|
SQNM / Sequenom, Inc.
|
|
|
4,681,026 |
|
|
|
2012-02-14 |
13G/A
|
POZN / Pozen, Inc.
|
|
|
2,946,944 |
|
|
|
2012-02-14 |
13G/A
|
SVRA / Savara Inc.
|
|
|
0 |
|
|
|
2012-02-14 |
13G/A
|
TNGNQ / Tengion, Inc.
|
|
|
1,060,070 |
|
|
|
2012-02-14 |
13G/A
|
US0906721065 / BioTelemetry, Inc.
|
|
|
0 |
|
|
|
2012-02-14 |
13G/A
|
ALXA / Alexza Pharmaceuticals, Inc.
|
|
|
1,622,967 |
|
|
|
2012-02-14 |
13G/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
5,269,999 |
|
|
|
2012-02-14 |
13G/A
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
|
2,444,732 |
|
|
|
2012-02-14 |
13G/A
|
ASMB / Assembly Biosciences, Inc.
|
|
|
718,519 |
|
|
|
2012-02-14 |
13G/A
|
GNTA / Genenta Science S.p.A. - Depositary Receipt (Common Stock)
|
|
|
210,536,030 |
|
|
|
2012-02-14 |
13G/A
|
DSCI / Derma Sciences, Inc.
|
|
|
1,055,648 |
|
|
|
2012-02-14 |
13G/A
|
DYAX / Dyax Corp.
|
|
|
7,072,436 |
|
|
|
2012-02-14 |
13G/A
|
GEVA / Synageva Biopharma Corp
|
|
|
0 |
|
|
|
2012-02-14 |
13G/A
|
ACHV / Achieve Life Sciences, Inc.
|
|
|
659,051 |
|
|
|